search
Back to results

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Primary Purpose

Pulmonary Disease, Chronic Obstructive

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
fluticasone furoate/vilanterol
fluticasone furoate
vilanterol
Placebo
Sponsored by
GlaxoSmithKline
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring COPD, Cardiovascular disease, Novel Dry Powder Inhaler, Survival

Eligibility Criteria

40 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type of subject: outpatient.
  • Informed consent: Subjects must give their signed and dated written informed consent to participate.
  • Gender: Male or female. Female subjects must be post-menopausal or using a highly effective method for avoidance of pregnancy. The decision to include or exclude women of childbearing potential may be made at the discretion of the investigator in accordance with local practice in relation to adequate contraception.
  • Age: >=40 and <=80 years of age at Screening (Visit 1).
  • Tobacco use: Subjects with a current or prior history of >=10 pack-years of cigarette smoking at screening (Visit 1). Previous smokers are defined as those who have stopped smoking for at least 6 months prior to Visit 1.
  • Airflow Obstruction:

Subjects with a measured post-albuterol/salbutamol forced expiratory volume in 1 second (FEV1)/(forced vital capacity)FVC ratio of <=0.70 at Screening (Visit 1).

Subjects with a measured post-albuterol/salbutamol FEV1 >=50 and <=70% of predicted normal values calculated using NHANES III reference equations [Hankinson, 1999; Hankinson, 2010] at Screening (Visit 1).

Post-bronchodilator spirometry will be performed approximately 15 minutes after the subject has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via a metered dose inhaler (MDI )with a valved-holding chamber. The FEV1/FVC ratio and FEV1 percent predicted values will be calculated.

  • Symptoms of COPD: Subjects must score 2 or higher on the modified Medical Research Council Dyspnea scale (Visit 1)
  • Cardiovascular disease:

For patients >= 40 years of age: any one of the following:

Established (i.e. by clinical signs or imaging studies) coronary artery disease (CAD) Established (i.e. by clinical signs or imaging studies) peripheral vascular disease (PVD) Previous stroke Previous MI Diabetes mellitus with target organ disease OR

For patients >=60 years of age: any 2 of the following:

Being treated for hypercholesterolemia Being treated for hypertension Being treated for diabetes mellitus Being treated for peripheral vascular disease

Exclusion Criteria:

  • Pregnancy: Women who are pregnant or lactating.
  • Asthma: Subjects with a current diagnosis of asthma. (Subjects with a prior history of asthma are eligible if they also have a current diagnosis of COPD).
  • alpha 1-antitrypsin deficiency: Subjects with known alpha-1 antitrypsin deficiency as the underlying cause of COPD.
  • Other respiratory disorders: Subjects with active tuberculosis, lung cancer, bronchiectasis, sarcoidosis, pulmonary fibrosis, pulmonary hypertension, interstitial lung diseases or other active pulmonary diseases.
  • Lung resection or transplantation: Subjects with lung volume reduction surgery within the 12 months prior to Screening or having had a lung transplant.
  • A moderate/severe COPD exacerbation that has not resolved at least 14 days prior to Visit 1 and at least 30 days following the last dose of oral corticosteroids (if applicable).
  • Current severe heart failure (New York Heart Association class IV). Subjects will also be excluded if they have a known ejection fraction of <30% or if they have an implantable cardioverter defibrillator (ICD).
  • Other diseases/abnormalities: Any life-threatening condition with life expectancy <3 years, other than vascular disease or COPD, that might prevent the subject from completing the study.
  • End stage chronic renal disease: Subjects will be excluded if on renal replacement therapy (hemodialysis or peritoneal).
  • Drug/food allergy: Subjects with a history of hypersensitivity to any of the study medications (e.g. beta-agonists, corticosteroid) or components of the inhalation powder (e.g. lactose, magnesium stearate). In addition, patients with a history of severe milk protein allergy that, in the opinion of the study physician, contraindicates the subject's participation will also be excluded.
  • Drug/alcohol abuse: Subjects with a known or suspected history of alcohol or drug abuse within the last 2 years.
  • Oxygen therapy: Subjects receiving treatment with long-term oxygen therapy (LTOT) or nocturnal oxygen therapy required for greater than 12 hours a day. Oxygen prn use (i.e. <=12 hours per day) is not exclusionary.
  • Questionable validity of consent: Subjects with a history of psychiatric disease, intellectual deficiency, poor motivation or other conditions that will limit the validity of informed consent to participate in the study or the potential compliance to study procedures.
  • Affiliation with investigator site: Study investigators, sub-investigators, study coordinators, employees of a participating investigator or immediate family members of the aforementioned are excluded from participating in this study.
  • Additional medication: Use of the following medications within the following time intervals prior to Visit 1 or during the study (unless otherwise specified):

Medication No use within the following time intervals prior to Screening or thereafter at any time during the study (unless otherwise specified) Inhaled Long acting beta-agonists (LABA) 48 hours ICS/LABA combination products 48 hours Inhaled corticosteroids 48 hours Tiotropium 1 week Systemic, Oral, parenteral, intra-articular corticosteroids 30 days (oral and systemic corticosteroids may be used to treat COPD exacerbations during the study) Cytochrome P450 3A4 strong inhibitors including but not limited to antiretrovirals (protease inhibitors) (e.g.Indinavir, Nelfinavir, Ritonavir, Saquinavir); Imidazole and Triazole anti-fungals (e.g. Ketaconazole, Itraconazole); Clarithromycin, Telithromycin, Amiodarone, and Nefazodone 6 weeks Grapefruit is allowed up to Visit 1, then limited to no more than one glass of grapefruit juice (250 mL/ 8 ounces) or one grapefruit per day Any other investigational drug 30 days or 5 half lives whichever is longer.

Sites / Locations

  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site
  • GSK Investigational Site

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

fluticasone furoate/vilanterol

fluticasone furoate

vilanterol

placebo

Arm Description

Combination of both products in one inhaler

comparator of individual component

comparator of individual component

once daily via inhaler

Outcomes

Primary Outcome Measures

Number of Participants With Death (Both on and Off Treatment) Due to Any Cause, Time up to or on the Pre-determined Common End Date
Death from any cause: which occurred from the day of starting IP until the Commone End Date (CED). Common End Date (CED) is the study end date that was pre determined where approximately 1000 deaths would have occurred in the Intent-toTreat Efficacy (ITT-E) Population. Only deaths which occurred on or before the CED were used for the primary analysis. Those who had not died by CED, but who were known to be alive on or after the CED, were censored at the CED. Cox Proportional Hazards (PH) Model was adjusted for age, and gender, including all 4 arms. A hazard ratio of less than 1 indicates a lower death rate versus placebo or other arm. ITT-E Population consisted of all participants in the Safety Population (i.e. randomized to IP and who received at least one dose of IP), with the exception of those recruited at sites that were closed.

Secondary Outcome Measures

Decline in Forced Expiratory Volume in 1 Second (FEV1)
FEV1 is a measure of lung function and is defined as the maximal amount of air that can be forcefully exhaled in one second. The effect of treatment on decline of post bronchodilator FEV1 recorded during the treatment period was analyzed using a particular form of a mixed effect model - a random coefficients model. FEV1 was fitted as the response variable with treatment group, age, gender, baseline FEV1 and time on treatment as fixed effects. Time on treatment was treated as a continuous variable. This model allowed for an initial increase in FEV1, but then tested the difference in slopes from the first post-baseline measurement which was at 3 months. A negative slope indicates a decline. A positive treatment difference indicates a slower rate of decline vs Placebo or Component. Only participants with at least one on-treatment post-bronchodilator FEV1 measurement were analyzed.
Number of Participants With First On-treatment Cardiovascular (CV) Composite Events Occured on or Before Common End Date
On-treatment CV composite event is comprised of the first event that is adjudicated as on-treatment CV death, myocardial infarction, stroke, unstable angina, or transient ischemic attack experienced by a participant. The events that occurred no more than 7 days after the participants last dose of IP are considered as on-treatment adverse events. Common end date is the study end date where approximately 1000 deaths would have occurred in the ITT-E Population. Cox PH Model was used to assess time to first on-treatment CV composite event. Cox PH Model was adjusted for age, gender and indicators of ischemic and vascular disease, including all four treatment arms. A hazard ratio less than 1 indicates a lower risk of a first CV event rate versus placebo or any arm.

Full Information

First Posted
February 3, 2011
Last Updated
August 2, 2018
Sponsor
GlaxoSmithKline
search

1. Study Identification

Unique Protocol Identification Number
NCT01313676
Brief Title
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Official Title
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
January 25, 2011 (Actual)
Primary Completion Date
July 15, 2015 (Actual)
Study Completion Date
July 15, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
GlaxoSmithKline

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if fluticasone furoate/vilanterol improves survival in patients with chronic obstructive pulmonary disease with a history of or increased risk of heart disease.
Detailed Description
Despite a potential link between the pathogenetic mechanisms involved in Chronic Obstructive Pulmonary Disease (COPD) and atherosclerotic cardiovascular disease, there are no currently approved therapies for patients with COPD that have clearly shown an additional beneficial effect in patients with cardiovascular comorbidities. The TOwards a Revolution in COPD Health (TORCH) study assessed the impact of the inhaled corticosteroid (ICS) fluticasone propionate (FP) in combination with the long-acting beta agonist (LABA), salmeterol (SAL), in reducing all-cause mortality. TORCH demonstrated a 17.5% reduction on all-cause mortality with salmeterol-fluticasone propionate combination (SFC) compared with placebo (HR=0.825, 95% CI (0.681, 1.002), p=0.052) in the entire COPD population with disease severity form moderate to very severe. A post hoc analysis of the data restricted to those subjects with an forced expiratory volume in 1 second (FEV1) >=50% predicted with an apparent history of cardiovascular co-morbidities (defined as use at baseline of beta-blockers, angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB), HMG CoA reductase inhibitors (i.e. statins) or a prior MI recorded at baseline) demonstrated a 49% reduction in the risk of dying within 96 weeks for the comparison of SFC with placebo. These post hoc data suggest the possibility of an ICS/LABA combination product to be of substantial benefit in COPD subjects with less severe airflow obstruction yet with increased cardiovascular risk. The mechanism by which SFC appears to be associated with a greater reduction in mortality in these less severe COPD subjects with concomitant cardiovascular comorbidities is speculative at present, but could potentially in part be related to a lessening of the degree of inflammation in the systemic circulation, potential plaque stabilization and/or amelioration of arterial stiffness. ICS/LABA combinations that are currently available require twice daily administration. A once daily ICS/LABA combination has the potential to improve patient compliance and as a result, overall disease management. The purpose of this study is to prospectively evaluate the effect of the once daily ICS/LABA combination Fluticasone Furoate (FF)/Vilanterol (VI) on survival in subjects with moderate COPD (>=50 and =<70 % predicted FEV1 ) and a history of, or at increased risk for cardiovascular disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive
Keywords
COPD, Cardiovascular disease, Novel Dry Powder Inhaler, Survival

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
16568 (Actual)

8. Arms, Groups, and Interventions

Arm Title
fluticasone furoate/vilanterol
Arm Type
Experimental
Arm Description
Combination of both products in one inhaler
Arm Title
fluticasone furoate
Arm Type
Experimental
Arm Description
comparator of individual component
Arm Title
vilanterol
Arm Type
Experimental
Arm Description
comparator of individual component
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
once daily via inhaler
Intervention Type
Drug
Intervention Name(s)
fluticasone furoate/vilanterol
Intervention Description
100/25mcg given once daily via novel dry powder inhaler
Intervention Type
Drug
Intervention Name(s)
fluticasone furoate
Intervention Description
100mcg given once daily via novel dry powder inhaler
Intervention Type
Drug
Intervention Name(s)
vilanterol
Intervention Description
25mcg given once daily via novel dry powder inhaler
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
placebo comparator once daily via novel dry powder inhaler
Primary Outcome Measure Information:
Title
Number of Participants With Death (Both on and Off Treatment) Due to Any Cause, Time up to or on the Pre-determined Common End Date
Description
Death from any cause: which occurred from the day of starting IP until the Commone End Date (CED). Common End Date (CED) is the study end date that was pre determined where approximately 1000 deaths would have occurred in the Intent-toTreat Efficacy (ITT-E) Population. Only deaths which occurred on or before the CED were used for the primary analysis. Those who had not died by CED, but who were known to be alive on or after the CED, were censored at the CED. Cox Proportional Hazards (PH) Model was adjusted for age, and gender, including all 4 arms. A hazard ratio of less than 1 indicates a lower death rate versus placebo or other arm. ITT-E Population consisted of all participants in the Safety Population (i.e. randomized to IP and who received at least one dose of IP), with the exception of those recruited at sites that were closed.
Time Frame
From the date of randomization until date of death due to any cause (average of 2 study years)
Secondary Outcome Measure Information:
Title
Decline in Forced Expiratory Volume in 1 Second (FEV1)
Description
FEV1 is a measure of lung function and is defined as the maximal amount of air that can be forcefully exhaled in one second. The effect of treatment on decline of post bronchodilator FEV1 recorded during the treatment period was analyzed using a particular form of a mixed effect model - a random coefficients model. FEV1 was fitted as the response variable with treatment group, age, gender, baseline FEV1 and time on treatment as fixed effects. Time on treatment was treated as a continuous variable. This model allowed for an initial increase in FEV1, but then tested the difference in slopes from the first post-baseline measurement which was at 3 months. A negative slope indicates a decline. A positive treatment difference indicates a slower rate of decline vs Placebo or Component. Only participants with at least one on-treatment post-bronchodilator FEV1 measurement were analyzed.
Time Frame
From start date of IP until IP stop date + 1 (assessed up to 4 years)
Title
Number of Participants With First On-treatment Cardiovascular (CV) Composite Events Occured on or Before Common End Date
Description
On-treatment CV composite event is comprised of the first event that is adjudicated as on-treatment CV death, myocardial infarction, stroke, unstable angina, or transient ischemic attack experienced by a participant. The events that occurred no more than 7 days after the participants last dose of IP are considered as on-treatment adverse events. Common end date is the study end date where approximately 1000 deaths would have occurred in the ITT-E Population. Cox PH Model was used to assess time to first on-treatment CV composite event. Cox PH Model was adjusted for age, gender and indicators of ischemic and vascular disease, including all four treatment arms. A hazard ratio less than 1 indicates a lower risk of a first CV event rate versus placebo or any arm.
Time Frame
From the start of IP to first on treatment CV event till 7 days after the last dose of IP (average of 2 study years)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type of subject: outpatient. Informed consent: Subjects must give their signed and dated written informed consent to participate. Gender: Male or female. Female subjects must be post-menopausal or using a highly effective method for avoidance of pregnancy. The decision to include or exclude women of childbearing potential may be made at the discretion of the investigator in accordance with local practice in relation to adequate contraception. Age: >=40 and <=80 years of age at Screening (Visit 1). Tobacco use: Subjects with a current or prior history of >=10 pack-years of cigarette smoking at screening (Visit 1). Previous smokers are defined as those who have stopped smoking for at least 6 months prior to Visit 1. Airflow Obstruction: Subjects with a measured post-albuterol/salbutamol forced expiratory volume in 1 second (FEV1)/(forced vital capacity)FVC ratio of <=0.70 at Screening (Visit 1). Subjects with a measured post-albuterol/salbutamol FEV1 >=50 and <=70% of predicted normal values calculated using NHANES III reference equations [Hankinson, 1999; Hankinson, 2010] at Screening (Visit 1). Post-bronchodilator spirometry will be performed approximately 15 minutes after the subject has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via a metered dose inhaler (MDI )with a valved-holding chamber. The FEV1/FVC ratio and FEV1 percent predicted values will be calculated. Symptoms of COPD: Subjects must score 2 or higher on the modified Medical Research Council Dyspnea scale (Visit 1) Cardiovascular disease: For patients >= 40 years of age: any one of the following: Established (i.e. by clinical signs or imaging studies) coronary artery disease (CAD) Established (i.e. by clinical signs or imaging studies) peripheral vascular disease (PVD) Previous stroke Previous MI Diabetes mellitus with target organ disease OR For patients >=60 years of age: any 2 of the following: Being treated for hypercholesterolemia Being treated for hypertension Being treated for diabetes mellitus Being treated for peripheral vascular disease Exclusion Criteria: Pregnancy: Women who are pregnant or lactating. Asthma: Subjects with a current diagnosis of asthma. (Subjects with a prior history of asthma are eligible if they also have a current diagnosis of COPD). alpha 1-antitrypsin deficiency: Subjects with known alpha-1 antitrypsin deficiency as the underlying cause of COPD. Other respiratory disorders: Subjects with active tuberculosis, lung cancer, bronchiectasis, sarcoidosis, pulmonary fibrosis, pulmonary hypertension, interstitial lung diseases or other active pulmonary diseases. Lung resection or transplantation: Subjects with lung volume reduction surgery within the 12 months prior to Screening or having had a lung transplant. A moderate/severe COPD exacerbation that has not resolved at least 14 days prior to Visit 1 and at least 30 days following the last dose of oral corticosteroids (if applicable). Current severe heart failure (New York Heart Association class IV). Subjects will also be excluded if they have a known ejection fraction of <30% or if they have an implantable cardioverter defibrillator (ICD). Other diseases/abnormalities: Any life-threatening condition with life expectancy <3 years, other than vascular disease or COPD, that might prevent the subject from completing the study. End stage chronic renal disease: Subjects will be excluded if on renal replacement therapy (hemodialysis or peritoneal). Drug/food allergy: Subjects with a history of hypersensitivity to any of the study medications (e.g. beta-agonists, corticosteroid) or components of the inhalation powder (e.g. lactose, magnesium stearate). In addition, patients with a history of severe milk protein allergy that, in the opinion of the study physician, contraindicates the subject's participation will also be excluded. Drug/alcohol abuse: Subjects with a known or suspected history of alcohol or drug abuse within the last 2 years. Oxygen therapy: Subjects receiving treatment with long-term oxygen therapy (LTOT) or nocturnal oxygen therapy required for greater than 12 hours a day. Oxygen prn use (i.e. <=12 hours per day) is not exclusionary. Questionable validity of consent: Subjects with a history of psychiatric disease, intellectual deficiency, poor motivation or other conditions that will limit the validity of informed consent to participate in the study or the potential compliance to study procedures. Affiliation with investigator site: Study investigators, sub-investigators, study coordinators, employees of a participating investigator or immediate family members of the aforementioned are excluded from participating in this study. Additional medication: Use of the following medications within the following time intervals prior to Visit 1 or during the study (unless otherwise specified): Medication No use within the following time intervals prior to Screening or thereafter at any time during the study (unless otherwise specified) Inhaled Long acting beta-agonists (LABA) 48 hours ICS/LABA combination products 48 hours Inhaled corticosteroids 48 hours Tiotropium 1 week Systemic, Oral, parenteral, intra-articular corticosteroids 30 days (oral and systemic corticosteroids may be used to treat COPD exacerbations during the study) Cytochrome P450 3A4 strong inhibitors including but not limited to antiretrovirals (protease inhibitors) (e.g.Indinavir, Nelfinavir, Ritonavir, Saquinavir); Imidazole and Triazole anti-fungals (e.g. Ketaconazole, Itraconazole); Clarithromycin, Telithromycin, Amiodarone, and Nefazodone 6 weeks Grapefruit is allowed up to Visit 1, then limited to no more than one glass of grapefruit juice (250 mL/ 8 ounces) or one grapefruit per day Any other investigational drug 30 days or 5 half lives whichever is longer.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
GSK Clinical Trials
Organizational Affiliation
GlaxoSmithKline
Official's Role
Study Director
Facility Information:
Facility Name
GSK Investigational Site
City
Andalusia
State/Province
Alabama
ZIP/Postal Code
36420
Country
United States
Facility Name
GSK Investigational Site
City
Athens
State/Province
Alabama
ZIP/Postal Code
35611
Country
United States
Facility Name
GSK Investigational Site
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35209
Country
United States
Facility Name
GSK Investigational Site
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35216
Country
United States
Facility Name
GSK Investigational Site
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35233
Country
United States
Facility Name
GSK Investigational Site
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35242
Country
United States
Facility Name
GSK Investigational Site
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35801
Country
United States
Facility Name
GSK Investigational Site
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35816
Country
United States
Facility Name
GSK Investigational Site
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36604
Country
United States
Facility Name
GSK Investigational Site
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36608
Country
United States
Facility Name
GSK Investigational Site
City
Montgomery
State/Province
Alabama
ZIP/Postal Code
36106
Country
United States
Facility Name
GSK Investigational Site
City
Montgomery
State/Province
Alabama
ZIP/Postal Code
36109
Country
United States
Facility Name
GSK Investigational Site
City
Muscle Shoals
State/Province
Alabama
ZIP/Postal Code
35662
Country
United States
Facility Name
GSK Investigational Site
City
Ozark
State/Province
Alabama
ZIP/Postal Code
36360
Country
United States
Facility Name
GSK Investigational Site
City
Pell City
State/Province
Alabama
ZIP/Postal Code
35128
Country
United States
Facility Name
GSK Investigational Site
City
Tuscumbia
State/Province
Alabama
ZIP/Postal Code
35674
Country
United States
Facility Name
GSK Investigational Site
City
Flagstaff
State/Province
Arizona
ZIP/Postal Code
86001
Country
United States
Facility Name
GSK Investigational Site
City
Glendale
State/Province
Arizona
ZIP/Postal Code
85306
Country
United States
Facility Name
GSK Investigational Site
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85018
Country
United States
Facility Name
GSK Investigational Site
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85032
Country
United States
Facility Name
GSK Investigational Site
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85258
Country
United States
Facility Name
GSK Investigational Site
City
Sierra Vista
State/Province
Arizona
ZIP/Postal Code
85635
Country
United States
Facility Name
GSK Investigational Site
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85710
Country
United States
Facility Name
GSK Investigational Site
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85745
Country
United States
Facility Name
GSK Investigational Site
City
Fayetteville
State/Province
Arkansas
ZIP/Postal Code
72703
Country
United States
Facility Name
GSK Investigational Site
City
Jonesboro
State/Province
Arkansas
ZIP/Postal Code
72401
Country
United States
Facility Name
GSK Investigational Site
City
Anaheim
State/Province
California
ZIP/Postal Code
92801
Country
United States
Facility Name
GSK Investigational Site
City
Bakersfield
State/Province
California
ZIP/Postal Code
93301
Country
United States
Facility Name
GSK Investigational Site
City
Cerritos
State/Province
California
ZIP/Postal Code
90703
Country
United States
Facility Name
GSK Investigational Site
City
Encinitas
State/Province
California
ZIP/Postal Code
92024
Country
United States
Facility Name
GSK Investigational Site
City
Foothill Ranch
State/Province
California
ZIP/Postal Code
92610
Country
United States
Facility Name
GSK Investigational Site
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Facility Name
GSK Investigational Site
City
Garden Grove
State/Province
California
ZIP/Postal Code
92844
Country
United States
Facility Name
GSK Investigational Site
City
Gold River
State/Province
California
ZIP/Postal Code
95670
Country
United States
Facility Name
GSK Investigational Site
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92647
Country
United States
Facility Name
GSK Investigational Site
City
Huntington Park
State/Province
California
ZIP/Postal Code
90255
Country
United States
Facility Name
GSK Investigational Site
City
Lakewood
State/Province
California
ZIP/Postal Code
90712
Country
United States
Facility Name
GSK Investigational Site
City
Lancaster
State/Province
California
ZIP/Postal Code
93534
Country
United States
Facility Name
GSK Investigational Site
City
Loma Linda
State/Province
California
ZIP/Postal Code
92357
Country
United States
Facility Name
GSK Investigational Site
City
Long Beach
State/Province
California
ZIP/Postal Code
90822
Country
United States
Facility Name
GSK Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Facility Name
GSK Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90036
Country
United States
Facility Name
GSK Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90048
Country
United States
Facility Name
GSK Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Facility Name
GSK Investigational Site
City
Mission Hills
State/Province
California
ZIP/Postal Code
91345
Country
United States
Facility Name
GSK Investigational Site
City
Mission Viejo
State/Province
California
ZIP/Postal Code
92691
Country
United States
Facility Name
GSK Investigational Site
City
Modesto
State/Province
California
ZIP/Postal Code
95350
Country
United States
Facility Name
GSK Investigational Site
City
Montclair
State/Province
California
ZIP/Postal Code
91763
Country
United States
Facility Name
GSK Investigational Site
City
Monterey Park
State/Province
California
ZIP/Postal Code
91754
Country
United States
Facility Name
GSK Investigational Site
City
Oxnard
State/Province
California
ZIP/Postal Code
93030-5841
Country
United States
Facility Name
GSK Investigational Site
City
Palo Alto
State/Province
California
ZIP/Postal Code
94304
Country
United States
Facility Name
GSK Investigational Site
City
Pasadena
State/Province
California
ZIP/Postal Code
91105
Country
United States
Facility Name
GSK Investigational Site
City
Pismo Beach
State/Province
California
ZIP/Postal Code
93449
Country
United States
Facility Name
GSK Investigational Site
City
Rancho Mirage
State/Province
California
ZIP/Postal Code
92270
Country
United States
Facility Name
GSK Investigational Site
City
Riverside
State/Province
California
ZIP/Postal Code
92506
Country
United States
Facility Name
GSK Investigational Site
City
Rolling Hills Estates
State/Province
California
ZIP/Postal Code
90274
Country
United States
Facility Name
GSK Investigational Site
City
Sacramento
State/Province
California
ZIP/Postal Code
95816
Country
United States
Facility Name
GSK Investigational Site
City
Sacramento
State/Province
California
ZIP/Postal Code
95817
Country
United States
Facility Name
GSK Investigational Site
City
Sacramento
State/Province
California
ZIP/Postal Code
95819
Country
United States
Facility Name
GSK Investigational Site
City
Sacramento
State/Province
California
ZIP/Postal Code
95821
Country
United States
Facility Name
GSK Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
91910
Country
United States
Facility Name
GSK Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
GSK Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
92108
Country
United States
Facility Name
GSK Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
92111
Country
United States
Facility Name
GSK Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
92117
Country
United States
Facility Name
GSK Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
92120
Country
United States
Facility Name
GSK Investigational Site
City
San Gabriel
State/Province
California
ZIP/Postal Code
91776
Country
United States
Facility Name
GSK Investigational Site
City
San Jose
State/Province
California
ZIP/Postal Code
95116
Country
United States
Facility Name
GSK Investigational Site
City
San Marino
State/Province
California
ZIP/Postal Code
91108
Country
United States
Facility Name
GSK Investigational Site
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States
Facility Name
GSK Investigational Site
City
Sepulveda
State/Province
California
ZIP/Postal Code
91343
Country
United States
Facility Name
GSK Investigational Site
City
Simi Valley
State/Province
California
ZIP/Postal Code
93065
Country
United States
Facility Name
GSK Investigational Site
City
Stockton
State/Province
California
ZIP/Postal Code
95207
Country
United States
Facility Name
GSK Investigational Site
City
Torrance
State/Province
California
ZIP/Postal Code
90502
Country
United States
Facility Name
GSK Investigational Site
City
Torrance
State/Province
California
ZIP/Postal Code
90505
Country
United States
Facility Name
GSK Investigational Site
City
Van Nuys
State/Province
California
ZIP/Postal Code
91405
Country
United States
Facility Name
GSK Investigational Site
City
Ventura
State/Province
California
ZIP/Postal Code
93003
Country
United States
Facility Name
GSK Investigational Site
City
West Covina
State/Province
California
ZIP/Postal Code
91790
Country
United States
Facility Name
GSK Investigational Site
City
Centennial
State/Province
Colorado
ZIP/Postal Code
80112
Country
United States
Facility Name
GSK Investigational Site
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80907
Country
United States
Facility Name
GSK Investigational Site
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80910
Country
United States
Facility Name
GSK Investigational Site
City
Denver
State/Province
Colorado
ZIP/Postal Code
80206
Country
United States
Facility Name
GSK Investigational Site
City
Fort Collins
State/Province
Colorado
ZIP/Postal Code
80528
Country
United States
Facility Name
GSK Investigational Site
City
Fort Collins
State/Province
Colorado
ZIP/Postal Code
80538
Country
United States
Facility Name
GSK Investigational Site
City
Wheat Ridge
State/Province
Colorado
ZIP/Postal Code
80033
Country
United States
Facility Name
GSK Investigational Site
City
Danbury
State/Province
Connecticut
ZIP/Postal Code
06810
Country
United States
Facility Name
GSK Investigational Site
City
Hartford
State/Province
Connecticut
ZIP/Postal Code
06105
Country
United States
Facility Name
GSK Investigational Site
City
Waterbury
State/Province
Connecticut
ZIP/Postal Code
06708
Country
United States
Facility Name
GSK Investigational Site
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20422
Country
United States
Facility Name
GSK Investigational Site
City
Altamonte Springs
State/Province
Florida
ZIP/Postal Code
32714
Country
United States
Facility Name
GSK Investigational Site
City
Aventura
State/Province
Florida
ZIP/Postal Code
33180
Country
United States
Facility Name
GSK Investigational Site
City
Bay Pines
State/Province
Florida
ZIP/Postal Code
33744
Country
United States
Facility Name
GSK Investigational Site
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33435
Country
United States
Facility Name
GSK Investigational Site
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33472
Country
United States
Facility Name
GSK Investigational Site
City
Brandon
State/Province
Florida
ZIP/Postal Code
33511
Country
United States
Facility Name
GSK Investigational Site
City
Celebration
State/Province
Florida
ZIP/Postal Code
34747
Country
United States
Facility Name
GSK Investigational Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33755
Country
United States
Facility Name
GSK Investigational Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33756
Country
United States
Facility Name
GSK Investigational Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33759
Country
United States
Facility Name
GSK Investigational Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765-2616
Country
United States
Facility Name
GSK Investigational Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765
Country
United States
Facility Name
GSK Investigational Site
City
Crystal River
State/Province
Florida
ZIP/Postal Code
34429
Country
United States
Facility Name
GSK Investigational Site
City
Daytona Beach
State/Province
Florida
ZIP/Postal Code
32117
Country
United States
Facility Name
GSK Investigational Site
City
DeBary
State/Province
Florida
ZIP/Postal Code
32173
Country
United States
Facility Name
GSK Investigational Site
City
DeLand
State/Province
Florida
ZIP/Postal Code
32720
Country
United States
Facility Name
GSK Investigational Site
City
Edgewater
State/Province
Florida
ZIP/Postal Code
32132
Country
United States
Facility Name
GSK Investigational Site
City
Fleming Island
State/Province
Florida
ZIP/Postal Code
32003
Country
United States
Facility Name
GSK Investigational Site
City
Fort Lauderdale
State/Province
Florida
ZIP/Postal Code
33316
Country
United States
Facility Name
GSK Investigational Site
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32608
Country
United States
Facility Name
GSK Investigational Site
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33012
Country
United States
Facility Name
GSK Investigational Site
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33013
Country
United States
Facility Name
GSK Investigational Site
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
GSK Investigational Site
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33021
Country
United States
Facility Name
GSK Investigational Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32209
Country
United States
Facility Name
GSK Investigational Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Facility Name
GSK Investigational Site
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34741
Country
United States
Facility Name
GSK Investigational Site
City
Leesburg
State/Province
Florida
ZIP/Postal Code
34748
Country
United States
Facility Name
GSK Investigational Site
City
Lehigh Acres
State/Province
Florida
ZIP/Postal Code
33971
Country
United States
Facility Name
GSK Investigational Site
City
Maitland
State/Province
Florida
ZIP/Postal Code
32751
Country
United States
Facility Name
GSK Investigational Site
City
Melbourne
State/Province
Florida
ZIP/Postal Code
32934
Country
United States
Facility Name
GSK Investigational Site
City
Miami Gardens
State/Province
Florida
ZIP/Postal Code
33169
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33015
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33125
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33126
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33133
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33142
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33165
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33174
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33185
Country
United States
Facility Name
GSK Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33186
Country
United States
Facility Name
GSK Investigational Site
City
New Port Richey
State/Province
Florida
ZIP/Postal Code
34652
Country
United States
Facility Name
GSK Investigational Site
City
North Miami Beach
State/Province
Florida
ZIP/Postal Code
33179
Country
United States
Facility Name
GSK Investigational Site
City
Oakland Park
State/Province
Florida
ZIP/Postal Code
33309
Country
United States
Facility Name
GSK Investigational Site
City
Ocala
State/Province
Florida
ZIP/Postal Code
34471
Country
United States
Facility Name
GSK Investigational Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32803
Country
United States
Facility Name
GSK Investigational Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32811
Country
United States
Facility Name
GSK Investigational Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32825
Country
United States
Facility Name
GSK Investigational Site
City
Palm Harbor
State/Province
Florida
ZIP/Postal Code
34684
Country
United States
Facility Name
GSK Investigational Site
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33027
Country
United States
Facility Name
GSK Investigational Site
City
Pensacola
State/Province
Florida
ZIP/Postal Code
32503
Country
United States
Facility Name
GSK Investigational Site
City
Pensacola
State/Province
Florida
ZIP/Postal Code
32514
Country
United States
Facility Name
GSK Investigational Site
City
Pinellas Park
State/Province
Florida
ZIP/Postal Code
33781
Country
United States
Facility Name
GSK Investigational Site
City
Port Charlotte
State/Province
Florida
ZIP/Postal Code
33952
Country
United States
Facility Name
GSK Investigational Site
City
Port Orange
State/Province
Florida
ZIP/Postal Code
32129
Country
United States
Facility Name
GSK Investigational Site
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33704
Country
United States
Facility Name
GSK Investigational Site
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33707
Country
United States
Facility Name
GSK Investigational Site
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33709
Country
United States
Facility Name
GSK Investigational Site
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33713
Country
United States
Facility Name
GSK Investigational Site
City
Sarasota
State/Province
Florida
ZIP/Postal Code
34239
Country
United States
Facility Name
GSK Investigational Site
City
South Miami
State/Province
Florida
ZIP/Postal Code
33143
Country
United States
Facility Name
GSK Investigational Site
City
Summerfield
State/Province
Florida
ZIP/Postal Code
34491
Country
United States
Facility Name
GSK Investigational Site
City
Tamarac
State/Province
Florida
ZIP/Postal Code
33319
Country
United States
Facility Name
GSK Investigational Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33603
Country
United States
Facility Name
GSK Investigational Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33607
Country
United States
Facility Name
GSK Investigational Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Facility Name
GSK Investigational Site
City
Trinity
State/Province
Florida
ZIP/Postal Code
34655
Country
United States
Facility Name
GSK Investigational Site
City
Vero Beach
State/Province
Florida
ZIP/Postal Code
32958
Country
United States
Facility Name
GSK Investigational Site
City
Vero Beach
State/Province
Florida
ZIP/Postal Code
32960
Country
United States
Facility Name
GSK Investigational Site
City
Wellington
State/Province
Florida
ZIP/Postal Code
33414
Country
United States
Facility Name
GSK Investigational Site
City
Winter Park
State/Province
Florida
ZIP/Postal Code
32789
Country
United States
Facility Name
GSK Investigational Site
City
Zephyrhills
State/Province
Florida
ZIP/Postal Code
33540
Country
United States
Facility Name
GSK Investigational Site
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30342
Country
United States
Facility Name
GSK Investigational Site
City
Austell
State/Province
Georgia
ZIP/Postal Code
30106
Country
United States
Facility Name
GSK Investigational Site
City
Blue Ridge
State/Province
Georgia
ZIP/Postal Code
30513
Country
United States
Facility Name
GSK Investigational Site
City
Calhoun
State/Province
Georgia
ZIP/Postal Code
30701
Country
United States
Facility Name
GSK Investigational Site
City
Canton
State/Province
Georgia
ZIP/Postal Code
30114
Country
United States
Facility Name
GSK Investigational Site
City
Columbus
State/Province
Georgia
ZIP/Postal Code
31904
Country
United States
Facility Name
GSK Investigational Site
City
Cumming
State/Province
Georgia
ZIP/Postal Code
30041
Country
United States
Facility Name
GSK Investigational Site
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30033
Country
United States
Facility Name
GSK Investigational Site
City
Gainesville
State/Province
Georgia
ZIP/Postal Code
30501
Country
United States
Facility Name
GSK Investigational Site
City
Lawrenceville
State/Province
Georgia
ZIP/Postal Code
30046
Country
United States
Facility Name
GSK Investigational Site
City
Marietta
State/Province
Georgia
ZIP/Postal Code
30060
Country
United States
Facility Name
GSK Investigational Site
City
Rincon
State/Province
Georgia
ZIP/Postal Code
31326
Country
United States
Facility Name
GSK Investigational Site
City
Suwanee
State/Province
Georgia
ZIP/Postal Code
30024
Country
United States
Facility Name
GSK Investigational Site
City
Woodstock
State/Province
Georgia
ZIP/Postal Code
30189
Country
United States
Facility Name
GSK Investigational Site
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96813
Country
United States
Facility Name
GSK Investigational Site
City
Boise
State/Province
Idaho
ZIP/Postal Code
83642
Country
United States
Facility Name
GSK Investigational Site
City
Coeur d'Alene
State/Province
Idaho
ZIP/Postal Code
90212
Country
United States
Facility Name
GSK Investigational Site
City
Hayden Lake
State/Province
Idaho
ZIP/Postal Code
83835
Country
United States
Facility Name
GSK Investigational Site
City
Idaho Falls
State/Province
Idaho
ZIP/Postal Code
83402
Country
United States
Facility Name
GSK Investigational Site
City
Nampa
State/Province
Idaho
ZIP/Postal Code
83687
Country
United States
Facility Name
GSK Investigational Site
City
Aurora
State/Province
Illinois
ZIP/Postal Code
60504
Country
United States
Facility Name
GSK Investigational Site
City
Champaign
State/Province
Illinois
ZIP/Postal Code
61820
Country
United States
Facility Name
GSK Investigational Site
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60603
Country
United States
Facility Name
GSK Investigational Site
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Facility Name
GSK Investigational Site
City
Evergreen Park
State/Province
Illinois
ZIP/Postal Code
60805
Country
United States
Facility Name
GSK Investigational Site
City
Gillespie
State/Province
Illinois
ZIP/Postal Code
62033
Country
United States
Facility Name
GSK Investigational Site
City
Melrose Park
State/Province
Illinois
ZIP/Postal Code
60160
Country
United States
Facility Name
GSK Investigational Site
City
North Chicago
State/Province
Illinois
ZIP/Postal Code
60064
Country
United States
Facility Name
GSK Investigational Site
City
Oak Lawn
State/Province
Illinois
ZIP/Postal Code
60453
Country
United States
Facility Name
GSK Investigational Site
City
Peoria
State/Province
Illinois
ZIP/Postal Code
61602
Country
United States
Facility Name
GSK Investigational Site
City
Quincy
State/Province
Illinois
ZIP/Postal Code
62301
Country
United States
Facility Name
GSK Investigational Site
City
River Forest
State/Province
Illinois
ZIP/Postal Code
60305
Country
United States
Facility Name
GSK Investigational Site
City
Skokie
State/Province
Illinois
ZIP/Postal Code
60076
Country
United States
Facility Name
GSK Investigational Site
City
Avon
State/Province
Indiana
ZIP/Postal Code
46123
Country
United States
Facility Name
GSK Investigational Site
City
Elwood
State/Province
Indiana
ZIP/Postal Code
46036
Country
United States
Facility Name
GSK Investigational Site
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
Facility Name
GSK Investigational Site
City
Franklin
State/Province
Indiana
ZIP/Postal Code
46131
Country
United States
Facility Name
GSK Investigational Site
City
Greenfield
State/Province
Indiana
ZIP/Postal Code
46140
Country
United States
Facility Name
GSK Investigational Site
City
Muncie
State/Province
Indiana
ZIP/Postal Code
47304-5547
Country
United States
Facility Name
GSK Investigational Site
City
Valparaiso
State/Province
Indiana
ZIP/Postal Code
46383
Country
United States
Facility Name
GSK Investigational Site
City
Council Bluffs
State/Province
Iowa
ZIP/Postal Code
51503
Country
United States
Facility Name
GSK Investigational Site
City
Dubuque
State/Province
Iowa
ZIP/Postal Code
52001
Country
United States
Facility Name
GSK Investigational Site
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Facility Name
GSK Investigational Site
City
West Des Moines
State/Province
Iowa
ZIP/Postal Code
50265
Country
United States
Facility Name
GSK Investigational Site
City
Newton
State/Province
Kansas
ZIP/Postal Code
67114
Country
United States
Facility Name
GSK Investigational Site
City
Olathe
State/Province
Kansas
ZIP/Postal Code
66061
Country
United States
Facility Name
GSK Investigational Site
City
Topeka
State/Province
Kansas
ZIP/Postal Code
66606
Country
United States
Facility Name
GSK Investigational Site
City
Topeka
State/Province
Kansas
ZIP/Postal Code
66615
Country
United States
Facility Name
GSK Investigational Site
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67218
Country
United States
Facility Name
GSK Investigational Site
City
Bowling Green
State/Province
Kentucky
ZIP/Postal Code
42101
Country
United States
Facility Name
GSK Investigational Site
City
Crestview Hills
State/Province
Kentucky
ZIP/Postal Code
41017
Country
United States
Facility Name
GSK Investigational Site
City
Hawesville
State/Province
Kentucky
ZIP/Postal Code
42348
Country
United States
Facility Name
GSK Investigational Site
City
Hazard
State/Province
Kentucky
ZIP/Postal Code
41701
Country
United States
Facility Name
GSK Investigational Site
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40504
Country
United States
Facility Name
GSK Investigational Site
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Facility Name
GSK Investigational Site
City
Owensboro
State/Province
Kentucky
ZIP/Postal Code
42303-3163
Country
United States
Facility Name
GSK Investigational Site
City
Lafayette
State/Province
Louisiana
ZIP/Postal Code
70508
Country
United States
Facility Name
GSK Investigational Site
City
Metairie
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
GSK Investigational Site
City
Opelousas
State/Province
Louisiana
ZIP/Postal Code
70570
Country
United States
Facility Name
GSK Investigational Site
City
Auburn
State/Province
Maine
ZIP/Postal Code
04210
Country
United States
Facility Name
GSK Investigational Site
City
Bangor
State/Province
Maine
ZIP/Postal Code
04401
Country
United States
Facility Name
GSK Investigational Site
City
Biddeford
State/Province
Maine
ZIP/Postal Code
04005
Country
United States
Facility Name
GSK Investigational Site
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
Facility Name
GSK Investigational Site
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States
Facility Name
GSK Investigational Site
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21239
Country
United States
Facility Name
GSK Investigational Site
City
Columbia
State/Province
Maryland
ZIP/Postal Code
21044
Country
United States
Facility Name
GSK Investigational Site
City
Elkton
State/Province
Maryland
ZIP/Postal Code
21921
Country
United States
Facility Name
GSK Investigational Site
City
Hagerstown
State/Province
Maryland
ZIP/Postal Code
21740
Country
United States
Facility Name
GSK Investigational Site
City
Hollywood
State/Province
Maryland
ZIP/Postal Code
20636
Country
United States
Facility Name
GSK Investigational Site
City
Lutherville
State/Province
Maryland
ZIP/Postal Code
21093
Country
United States
Facility Name
GSK Investigational Site
City
Oxon Hill
State/Province
Maryland
ZIP/Postal Code
20745
Country
United States
Facility Name
GSK Investigational Site
City
Towson
State/Province
Maryland
ZIP/Postal Code
21204
Country
United States
Facility Name
GSK Investigational Site
City
Brockton
State/Province
Massachusetts
ZIP/Postal Code
02301
Country
United States
Facility Name
GSK Investigational Site
City
Fall River
State/Province
Massachusetts
ZIP/Postal Code
02720
Country
United States
Facility Name
GSK Investigational Site
City
North Dartmouth
State/Province
Massachusetts
ZIP/Postal Code
02747
Country
United States
Facility Name
GSK Investigational Site
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48106
Country
United States
Facility Name
GSK Investigational Site
City
Buckley
State/Province
Michigan
ZIP/Postal Code
49620
Country
United States
Facility Name
GSK Investigational Site
City
Cadillac
State/Province
Michigan
ZIP/Postal Code
49601
Country
United States
Facility Name
GSK Investigational Site
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48201
Country
United States
Facility Name
GSK Investigational Site
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48221
Country
United States
Facility Name
GSK Investigational Site
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48235
Country
United States
Facility Name
GSK Investigational Site
City
Grand Blanc
State/Province
Michigan
ZIP/Postal Code
48439
Country
United States
Facility Name
GSK Investigational Site
City
Kalamazoo
State/Province
Michigan
ZIP/Postal Code
49009
Country
United States
Facility Name
GSK Investigational Site
City
Niles
State/Province
Michigan
ZIP/Postal Code
49120
Country
United States
Facility Name
GSK Investigational Site
City
Rochester
State/Province
Michigan
ZIP/Postal Code
48307
Country
United States
Facility Name
GSK Investigational Site
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073-6769
Country
United States
Facility Name
GSK Investigational Site
City
Traverse City
State/Province
Michigan
ZIP/Postal Code
49684
Country
United States
Facility Name
GSK Investigational Site
City
Troy
State/Province
Michigan
ZIP/Postal Code
48085
Country
United States
Facility Name
GSK Investigational Site
City
Troy
State/Province
Michigan
ZIP/Postal Code
48098
Country
United States
Facility Name
GSK Investigational Site
City
Coon Rapids
State/Province
Minnesota
ZIP/Postal Code
55433
Country
United States
Facility Name
GSK Investigational Site
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55435
Country
United States
Facility Name
GSK Investigational Site
City
Fridley
State/Province
Minnesota
ZIP/Postal Code
55432
Country
United States
Facility Name
GSK Investigational Site
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55402
Country
United States
Facility Name
GSK Investigational Site
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55407
Country
United States
Facility Name
GSK Investigational Site
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55417
Country
United States
Facility Name
GSK Investigational Site
City
Plymouth
State/Province
Minnesota
ZIP/Postal Code
55441
Country
United States
Facility Name
GSK Investigational Site
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Facility Name
GSK Investigational Site
City
Saint Paul
State/Province
Minnesota
ZIP/Postal Code
55130
Country
United States
Facility Name
GSK Investigational Site
City
Woodbury
State/Province
Minnesota
ZIP/Postal Code
55125
Country
United States
Facility Name
GSK Investigational Site
City
Chesterfield
State/Province
Missouri
ZIP/Postal Code
63017
Country
United States
Facility Name
GSK Investigational Site
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64106
Country
United States
Facility Name
GSK Investigational Site
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64128
Country
United States
Facility Name
GSK Investigational Site
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63117
Country
United States
Facility Name
GSK Investigational Site
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
GSK Investigational Site
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63143
Country
United States
Facility Name
GSK Investigational Site
City
Billings
State/Province
Montana
ZIP/Postal Code
59101
Country
United States
Facility Name
GSK Investigational Site
City
Billings
State/Province
Montana
ZIP/Postal Code
59102
Country
United States
Facility Name
GSK Investigational Site
City
Butte
State/Province
Montana
ZIP/Postal Code
59701
Country
United States
Facility Name
GSK Investigational Site
City
Great Falls
State/Province
Montana
ZIP/Postal Code
59405
Country
United States
Facility Name
GSK Investigational Site
City
Missoula
State/Province
Montana
ZIP/Postal Code
59808
Country
United States
Facility Name
GSK Investigational Site
City
Bellevue
State/Province
Nebraska
ZIP/Postal Code
68123-4303
Country
United States
Facility Name
GSK Investigational Site
City
Fremont
State/Province
Nebraska
ZIP/Postal Code
68025
Country
United States
Facility Name
GSK Investigational Site
City
Grand Island
State/Province
Nebraska
ZIP/Postal Code
68803
Country
United States
Facility Name
GSK Investigational Site
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
02865
Country
United States
Facility Name
GSK Investigational Site
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68506
Country
United States
Facility Name
GSK Investigational Site
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68512
Country
United States
Facility Name
GSK Investigational Site
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68516
Country
United States
Facility Name
GSK Investigational Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68114
Country
United States
Facility Name
GSK Investigational Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68134
Country
United States
Facility Name
GSK Investigational Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68198
Country
United States
Facility Name
GSK Investigational Site
City
Henderson
State/Province
Nevada
ZIP/Postal Code
89014
Country
United States
Facility Name
GSK Investigational Site
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89106
Country
United States
Facility Name
GSK Investigational Site
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89119
Country
United States
Facility Name
GSK Investigational Site
City
Reno
State/Province
Nevada
ZIP/Postal Code
89502
Country
United States
Facility Name
GSK Investigational Site
City
Brick
State/Province
New Jersey
ZIP/Postal Code
08723
Country
United States
Facility Name
GSK Investigational Site
City
Edison
State/Province
New Jersey
ZIP/Postal Code
8820
Country
United States
Facility Name
GSK Investigational Site
City
Elizabeth
State/Province
New Jersey
ZIP/Postal Code
07201
Country
United States
Facility Name
GSK Investigational Site
City
Elizabeth
State/Province
New Jersey
ZIP/Postal Code
07202
Country
United States
Facility Name
GSK Investigational Site
City
Freehold
State/Province
New Jersey
ZIP/Postal Code
07728
Country
United States
Facility Name
GSK Investigational Site
City
Linden
State/Province
New Jersey
ZIP/Postal Code
07036
Country
United States
Facility Name
GSK Investigational Site
City
Lodi
State/Province
New Jersey
ZIP/Postal Code
07644
Country
United States
Facility Name
GSK Investigational Site
City
Margate City
State/Province
New Jersey
ZIP/Postal Code
08402
Country
United States
Facility Name
GSK Investigational Site
City
Princeton
State/Province
New Jersey
ZIP/Postal Code
08540
Country
United States
Facility Name
GSK Investigational Site
City
Salem
State/Province
New Jersey
ZIP/Postal Code
08079
Country
United States
Facility Name
GSK Investigational Site
City
Verona
State/Province
New Jersey
ZIP/Postal Code
07044
Country
United States
Facility Name
GSK Investigational Site
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87108
Country
United States
Facility Name
GSK Investigational Site
City
Albany
State/Province
New York
ZIP/Postal Code
12208
Country
United States
Facility Name
GSK Investigational Site
City
Bronxville
State/Province
New York
ZIP/Postal Code
10708
Country
United States
Facility Name
GSK Investigational Site
City
Bronx
State/Province
New York
ZIP/Postal Code
10457
Country
United States
Facility Name
GSK Investigational Site
City
Bronx
State/Province
New York
ZIP/Postal Code
10461
Country
United States
Facility Name
GSK Investigational Site
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11215
Country
United States
Facility Name
GSK Investigational Site
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11229
Country
United States
Facility Name
GSK Investigational Site
City
Buffalo
State/Province
New York
ZIP/Postal Code
14215-1199
Country
United States
Facility Name
GSK Investigational Site
City
Corning
State/Province
New York
ZIP/Postal Code
14830
Country
United States
Facility Name
GSK Investigational Site
City
Great Neck
State/Province
New York
ZIP/Postal Code
11023
Country
United States
Facility Name
GSK Investigational Site
City
Manhattan
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Facility Name
GSK Investigational Site
City
Massapequa
State/Province
New York
ZIP/Postal Code
11758
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10001
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10004
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10009
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10019
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10028
Country
United States
Facility Name
GSK Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10038
Country
United States
Facility Name
GSK Investigational Site
City
Rochester
State/Province
New York
ZIP/Postal Code
14618
Country
United States
Facility Name
GSK Investigational Site
City
Syracuse
State/Province
New York
ZIP/Postal Code
13210
Country
United States
Facility Name
GSK Investigational Site
City
Westfield
State/Province
New York
ZIP/Postal Code
14787
Country
United States
Facility Name
GSK Investigational Site
City
Asheville
State/Province
North Carolina
ZIP/Postal Code
28801
Country
United States
Facility Name
GSK Investigational Site
City
Calabash
State/Province
North Carolina
ZIP/Postal Code
28467
Country
United States
Facility Name
GSK Investigational Site
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28209
Country
United States
Facility Name
GSK Investigational Site
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28210
Country
United States
Facility Name
GSK Investigational Site
City
Elizabeth City
State/Province
North Carolina
ZIP/Postal Code
27909
Country
United States
Facility Name
GSK Investigational Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27401
Country
United States
Facility Name
GSK Investigational Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27403
Country
United States
Facility Name
GSK Investigational Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27405
Country
United States
Facility Name
GSK Investigational Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27408
Country
United States
Facility Name
GSK Investigational Site
City
Greenville
State/Province
North Carolina
ZIP/Postal Code
27858
Country
United States
Facility Name
GSK Investigational Site
City
High Point
State/Province
North Carolina
ZIP/Postal Code
27262
Country
United States
Facility Name
GSK Investigational Site
City
Huntersville
State/Province
North Carolina
ZIP/Postal Code
28078
Country
United States
Facility Name
GSK Investigational Site
City
Knightdale
State/Province
North Carolina
ZIP/Postal Code
27545
Country
United States
Facility Name
GSK Investigational Site
City
Lexington
State/Province
North Carolina
ZIP/Postal Code
27295
Country
United States
Facility Name
GSK Investigational Site
City
Morganton
State/Province
North Carolina
ZIP/Postal Code
28655
Country
United States
Facility Name
GSK Investigational Site
City
Salisbury
State/Province
North Carolina
ZIP/Postal Code
28144
Country
United States
Facility Name
GSK Investigational Site
City
Shelby
State/Province
North Carolina
ZIP/Postal Code
28152
Country
United States
Facility Name
GSK Investigational Site
City
Smithfield
State/Province
North Carolina
ZIP/Postal Code
27577
Country
United States
Facility Name
GSK Investigational Site
City
Statesville
State/Province
North Carolina
ZIP/Postal Code
28625
Country
United States
Facility Name
GSK Investigational Site
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
Facility Name
GSK Investigational Site
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
GSK Investigational Site
City
Akron
State/Province
Ohio
ZIP/Postal Code
44313
Country
United States
Facility Name
GSK Investigational Site
City
Chardon
State/Province
Ohio
ZIP/Postal Code
44024
Country
United States
Facility Name
GSK Investigational Site
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45220
Country
United States
Facility Name
GSK Investigational Site
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45231
Country
United States
Facility Name
GSK Investigational Site
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45242
Country
United States
Facility Name
GSK Investigational Site
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Facility Name
GSK Investigational Site
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44109
Country
United States
Facility Name
GSK Investigational Site
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44122
Country
United States
Facility Name
GSK Investigational Site
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43213
Country
United States
Facility Name
GSK Investigational Site
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43214
Country
United States
Facility Name
GSK Investigational Site
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43215
Country
United States
Facility Name
GSK Investigational Site
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43235
Country
United States
Facility Name
GSK Investigational Site
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45406
Country
United States
Facility Name
GSK Investigational Site
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45459
Country
United States
Facility Name
GSK Investigational Site
City
Kettering
State/Province
Ohio
ZIP/Postal Code
45429
Country
United States
Facility Name
GSK Investigational Site
City
Marion
State/Province
Ohio
ZIP/Postal Code
43302
Country
United States
Facility Name
GSK Investigational Site
City
Maumee
State/Province
Ohio
ZIP/Postal Code
43537-9402
Country
United States
Facility Name
GSK Investigational Site
City
Miamisburg
State/Province
Ohio
ZIP/Postal Code
45342
Country
United States
Facility Name
GSK Investigational Site
City
Toledo
State/Province
Ohio
ZIP/Postal Code
43606
Country
United States
Facility Name
GSK Investigational Site
City
Toledo
State/Province
Ohio
ZIP/Postal Code
43614-5809
Country
United States
Facility Name
GSK Investigational Site
City
Toledo
State/Province
Ohio
ZIP/Postal Code
43617
Country
United States
Facility Name
GSK Investigational Site
City
Wooster
State/Province
Ohio
ZIP/Postal Code
44691
Country
United States
Facility Name
GSK Investigational Site
City
Youngstown
State/Province
Ohio
ZIP/Postal Code
44501
Country
United States
Facility Name
GSK Investigational Site
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73103
Country
United States
Facility Name
GSK Investigational Site
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74127
Country
United States
Facility Name
GSK Investigational Site
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74136
Country
United States
Facility Name
GSK Investigational Site
City
Bend
State/Province
Oregon
ZIP/Postal Code
97701
Country
United States
Facility Name
GSK Investigational Site
City
Portland
State/Province
Oregon
ZIP/Postal Code
97202
Country
United States
Facility Name
GSK Investigational Site
City
Portland
State/Province
Oregon
ZIP/Postal Code
97219
Country
United States
Facility Name
GSK Investigational Site
City
Springfield
State/Province
Oregon
ZIP/Postal Code
97477
Country
United States
Facility Name
GSK Investigational Site
City
Beaver
State/Province
Pennsylvania
ZIP/Postal Code
15009
Country
United States
Facility Name
GSK Investigational Site
City
Belle Vernon
State/Province
Pennsylvania
ZIP/Postal Code
15012
Country
United States
Facility Name
GSK Investigational Site
City
Bensalem
State/Province
Pennsylvania
ZIP/Postal Code
19020
Country
United States
Facility Name
GSK Investigational Site
City
Clairton
State/Province
Pennsylvania
ZIP/Postal Code
15025
Country
United States
Facility Name
GSK Investigational Site
City
Downingtown
State/Province
Pennsylvania
ZIP/Postal Code
19335
Country
United States
Facility Name
GSK Investigational Site
City
Doylestown
State/Province
Pennsylvania
ZIP/Postal Code
18901
Country
United States
Facility Name
GSK Investigational Site
City
Erie
State/Province
Pennsylvania
ZIP/Postal Code
16508
Country
United States
Facility Name
GSK Investigational Site
City
Fleetwood
State/Province
Pennsylvania
ZIP/Postal Code
19522
Country
United States
Facility Name
GSK Investigational Site
City
Harleysville
State/Province
Pennsylvania
ZIP/Postal Code
19438
Country
United States
Facility Name
GSK Investigational Site
City
Jersey Shore
State/Province
Pennsylvania
ZIP/Postal Code
17740
Country
United States
Facility Name
GSK Investigational Site
City
Langhorne
State/Province
Pennsylvania
ZIP/Postal Code
19047
Country
United States
Facility Name
GSK Investigational Site
City
Lansdale
State/Province
Pennsylvania
ZIP/Postal Code
19446
Country
United States
Facility Name
GSK Investigational Site
City
Monroeville
State/Province
Pennsylvania
ZIP/Postal Code
15146
Country
United States
Facility Name
GSK Investigational Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Facility Name
GSK Investigational Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19140
Country
United States
Facility Name
GSK Investigational Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19142
Country
United States
Facility Name
GSK Investigational Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19152
Country
United States
Facility Name
GSK Investigational Site
City
Phoenixville
State/Province
Pennsylvania
ZIP/Postal Code
19460
Country
United States
Facility Name
GSK Investigational Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
GSK Investigational Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15236
Country
United States
Facility Name
GSK Investigational Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15243
Country
United States
Facility Name
GSK Investigational Site
City
Scottdale
State/Province
Pennsylvania
ZIP/Postal Code
15683
Country
United States
Facility Name
GSK Investigational Site
City
Scranton
State/Province
Pennsylvania
ZIP/Postal Code
18501
Country
United States
Facility Name
GSK Investigational Site
City
Uniontown
State/Province
Pennsylvania
ZIP/Postal Code
15401
Country
United States
Facility Name
GSK Investigational Site
City
Warminster
State/Province
Pennsylvania
ZIP/Postal Code
18974
Country
United States
Facility Name
GSK Investigational Site
City
Cumberland
State/Province
Rhode Island
ZIP/Postal Code
02864
Country
United States
Facility Name
GSK Investigational Site
City
East Providence
State/Province
Rhode Island
ZIP/Postal Code
02914
Country
United States
Facility Name
GSK Investigational Site
City
Johnston
State/Province
Rhode Island
ZIP/Postal Code
02919
Country
United States
Facility Name
GSK Investigational Site
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
Facility Name
GSK Investigational Site
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29406-7108
Country
United States
Facility Name
GSK Investigational Site
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29407
Country
United States
Facility Name
GSK Investigational Site
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29201
Country
United States
Facility Name
GSK Investigational Site
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29209
Country
United States
Facility Name
GSK Investigational Site
City
Easley
State/Province
South Carolina
ZIP/Postal Code
29640
Country
United States
Facility Name
GSK Investigational Site
City
Florence
State/Province
South Carolina
ZIP/Postal Code
29501
Country
United States
Facility Name
GSK Investigational Site
City
Gaffney
State/Province
South Carolina
ZIP/Postal Code
29340
Country
United States
Facility Name
GSK Investigational Site
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Facility Name
GSK Investigational Site
City
Greenwood
State/Province
South Carolina
ZIP/Postal Code
29646
Country
United States
Facility Name
GSK Investigational Site
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29650
Country
United States
Facility Name
GSK Investigational Site
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29651
Country
United States
Facility Name
GSK Investigational Site
City
Indian Land
State/Province
South Carolina
ZIP/Postal Code
29707
Country
United States
Facility Name
GSK Investigational Site
City
Murrells Inlet
State/Province
South Carolina
ZIP/Postal Code
29576
Country
United States
Facility Name
GSK Investigational Site
City
Pelzer
State/Province
South Carolina
ZIP/Postal Code
29669
Country
United States
Facility Name
GSK Investigational Site
City
Rock Hill
State/Province
South Carolina
ZIP/Postal Code
29732
Country
United States
Facility Name
GSK Investigational Site
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
GSK Investigational Site
City
Williamston
State/Province
South Carolina
ZIP/Postal Code
29697
Country
United States
Facility Name
GSK Investigational Site
City
Dakota Dunes
State/Province
South Dakota
ZIP/Postal Code
57049
Country
United States
Facility Name
GSK Investigational Site
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57702
Country
United States
Facility Name
GSK Investigational Site
City
Chattanooga
State/Province
Tennessee
ZIP/Postal Code
37404
Country
United States
Facility Name
GSK Investigational Site
City
Fayetteville
State/Province
Tennessee
ZIP/Postal Code
37334
Country
United States
Facility Name
GSK Investigational Site
City
Franklin
State/Province
Tennessee
ZIP/Postal Code
27064
Country
United States
Facility Name
GSK Investigational Site
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37215
Country
United States
Facility Name
GSK Investigational Site
City
Shelbyville
State/Province
Tennessee
ZIP/Postal Code
37160
Country
United States
Facility Name
GSK Investigational Site
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79124
Country
United States
Facility Name
GSK Investigational Site
City
Austin
State/Province
Texas
ZIP/Postal Code
78756
Country
United States
Facility Name
GSK Investigational Site
City
Austin
State/Province
Texas
ZIP/Postal Code
78758
Country
United States
Facility Name
GSK Investigational Site
City
Boerne
State/Province
Texas
ZIP/Postal Code
78006
Country
United States
Facility Name
GSK Investigational Site
City
Corpus Christi
State/Province
Texas
ZIP/Postal Code
78405
Country
United States
Facility Name
GSK Investigational Site
City
Corsicana
State/Province
Texas
ZIP/Postal Code
75110
Country
United States
Facility Name
GSK Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75216
Country
United States
Facility Name
GSK Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75225
Country
United States
Facility Name
GSK Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States
Facility Name
GSK Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75254
Country
United States
Facility Name
GSK Investigational Site
City
Duncanville
State/Province
Texas
ZIP/Postal Code
75116
Country
United States
Facility Name
GSK Investigational Site
City
Edinburg
State/Province
Texas
ZIP/Postal Code
78539
Country
United States
Facility Name
GSK Investigational Site
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Facility Name
GSK Investigational Site
City
Frisco
State/Province
Texas
ZIP/Postal Code
75034
Country
United States
Facility Name
GSK Investigational Site
City
Frisco
State/Province
Texas
ZIP/Postal Code
75035
Country
United States
Facility Name
GSK Investigational Site
City
Galveston
State/Province
Texas
ZIP/Postal Code
77555
Country
United States
Facility Name
GSK Investigational Site
City
Georgetown
State/Province
Texas
ZIP/Postal Code
78626
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77024
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77025
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77029
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77034
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77043
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77062
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77074
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77077
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77079
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
GSK Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77099
Country
United States
Facility Name
GSK Investigational Site
City
Huntsville
State/Province
Texas
ZIP/Postal Code
77340
Country
United States
Facility Name
GSK Investigational Site
City
Irving
State/Province
Texas
ZIP/Postal Code
75039
Country
United States
Facility Name
GSK Investigational Site
City
Killeen
State/Province
Texas
ZIP/Postal Code
76543
Country
United States
Facility Name
GSK Investigational Site
City
Kingwood
State/Province
Texas
ZIP/Postal Code
77339
Country
United States
Facility Name
GSK Investigational Site
City
Lewisville
State/Province
Texas
ZIP/Postal Code
75067
Country
United States
Facility Name
GSK Investigational Site
City
Longview
State/Province
Texas
ZIP/Postal Code
75605
Country
United States
Facility Name
GSK Investigational Site
City
Lufkin
State/Province
Texas
ZIP/Postal Code
75904
Country
United States
Facility Name
GSK Investigational Site
City
McKinney
State/Province
Texas
ZIP/Postal Code
75069
Country
United States
Facility Name
GSK Investigational Site
City
McKinney
State/Province
Texas
ZIP/Postal Code
75071
Country
United States
Facility Name
GSK Investigational Site
City
Plano
State/Province
Texas
ZIP/Postal Code
75075
Country
United States
Facility Name
GSK Investigational Site
City
San Angelo
State/Province
Texas
ZIP/Postal Code
76904
Country
United States
Facility Name
GSK Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78212
Country
United States
Facility Name
GSK Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78215
Country
United States
Facility Name
GSK Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
GSK Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78233
Country
United States
Facility Name
GSK Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78258
Country
United States
Facility Name
GSK Investigational Site
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77478
Country
United States
Facility Name
GSK Investigational Site
City
Temple
State/Province
Texas
ZIP/Postal Code
76508
Country
United States
Facility Name
GSK Investigational Site
City
Tyler
State/Province
Texas
ZIP/Postal Code
75701
Country
United States
Facility Name
GSK Investigational Site
City
Tyler
State/Province
Texas
ZIP/Postal Code
75708
Country
United States
Facility Name
GSK Investigational Site
City
Victoria
State/Province
Texas
ZIP/Postal Code
77901
Country
United States
Facility Name
GSK Investigational Site
City
Waco
State/Province
Texas
ZIP/Postal Code
76710
Country
United States
Facility Name
GSK Investigational Site
City
Midvale
State/Province
Utah
ZIP/Postal Code
84047
Country
United States
Facility Name
GSK Investigational Site
City
Orem
State/Province
Utah
ZIP/Postal Code
84058
Country
United States
Facility Name
GSK Investigational Site
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84102
Country
United States
Facility Name
GSK Investigational Site
City
West Jordan
State/Province
Utah
ZIP/Postal Code
84088
Country
United States
Facility Name
GSK Investigational Site
City
Abingdon
State/Province
Virginia
ZIP/Postal Code
24210
Country
United States
Facility Name
GSK Investigational Site
City
Alexandria
State/Province
Virginia
ZIP/Postal Code
22304
Country
United States
Facility Name
GSK Investigational Site
City
Burke
State/Province
Virginia
ZIP/Postal Code
22015
Country
United States
Facility Name
GSK Investigational Site
City
Midlothian
State/Province
Virginia
ZIP/Postal Code
23114
Country
United States
Facility Name
GSK Investigational Site
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23507
Country
United States
Facility Name
GSK Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23219
Country
United States
Facility Name
GSK Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23220
Country
United States
Facility Name
GSK Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23229
Country
United States
Facility Name
GSK Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23235
Country
United States
Facility Name
GSK Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23249
Country
United States
Facility Name
GSK Investigational Site
City
Virginia Beach
State/Province
Virginia
ZIP/Postal Code
23454
Country
United States
Facility Name
GSK Investigational Site
City
Winchester
State/Province
Virginia
ZIP/Postal Code
22601
Country
United States
Facility Name
GSK Investigational Site
City
Bellingham
State/Province
Washington
ZIP/Postal Code
98225
Country
United States
Facility Name
GSK Investigational Site
City
Burien
State/Province
Washington
ZIP/Postal Code
98166
Country
United States
Facility Name
GSK Investigational Site
City
Seattle
State/Province
Washington
ZIP/Postal Code
98104
Country
United States
Facility Name
GSK Investigational Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99202
Country
United States
Facility Name
GSK Investigational Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99204
Country
United States
Facility Name
GSK Investigational Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99207
Country
United States
Facility Name
GSK Investigational Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99208
Country
United States
Facility Name
GSK Investigational Site
City
Tacoma
State/Province
Washington
ZIP/Postal Code
98405
Country
United States
Facility Name
GSK Investigational Site
City
Bridgeport
State/Province
West Virginia
ZIP/Postal Code
26330
Country
United States
Facility Name
GSK Investigational Site
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26505
Country
United States
Facility Name
GSK Investigational Site
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
28506
Country
United States
Facility Name
GSK Investigational Site
City
West Allis
State/Province
Wisconsin
ZIP/Postal Code
53227
Country
United States
Facility Name
GSK Investigational Site
City
Adrogue
State/Province
Buenos Aires
ZIP/Postal Code
B1846DSK
Country
Argentina
Facility Name
GSK Investigational Site
City
Bahia Blanca
State/Province
Buenos Aires
ZIP/Postal Code
B8000FTD
Country
Argentina
Facility Name
GSK Investigational Site
City
Ciudad Autnónoma de Buenos Aires
State/Province
Buenos Aires
ZIP/Postal Code
C1186ACB
Country
Argentina
Facility Name
GSK Investigational Site
City
Ciudad Autonoma de Buenos Aires
State/Province
Buenos Aires
ZIP/Postal Code
C1028AAP
Country
Argentina
Facility Name
GSK Investigational Site
City
Ciudad Autonoma de Buenos Aires
State/Province
Buenos Aires
ZIP/Postal Code
C1122AAK
Country
Argentina
Facility Name
GSK Investigational Site
City
Ciudad Autonoma de Buenos Aires
State/Province
Buenos Aires
ZIP/Postal Code
C1405BCH
Country
Argentina
Facility Name
GSK Investigational Site
City
Derqui, Pilar
State/Province
Buenos Aires
ZIP/Postal Code
B1629AHJ
Country
Argentina
Facility Name
GSK Investigational Site
City
Florencio Varela
State/Province
Buenos Aires
ZIP/Postal Code
1888
Country
Argentina
Facility Name
GSK Investigational Site
City
La Plata
State/Province
Buenos Aires
ZIP/Postal Code
1900
Country
Argentina
Facility Name
GSK Investigational Site
City
La Plata
State/Province
Buenos Aires
ZIP/Postal Code
B1900AXI
Country
Argentina
Facility Name
GSK Investigational Site
City
Mar del Plata
State/Province
Buenos Aires
ZIP/Postal Code
B7600FZN
Country
Argentina
Facility Name
GSK Investigational Site
City
Nueve de Julio
State/Province
Buenos Aires
ZIP/Postal Code
B6500BWQ
Country
Argentina
Facility Name
GSK Investigational Site
City
Olivos
State/Province
Buenos Aires
ZIP/Postal Code
B1605DSX
Country
Argentina
Facility Name
GSK Investigational Site
City
Pergamino
State/Province
Buenos Aires
ZIP/Postal Code
B2700CPM
Country
Argentina
Facility Name
GSK Investigational Site
City
Quilmes
State/Province
Buenos Aires
ZIP/Postal Code
1878
Country
Argentina
Facility Name
GSK Investigational Site
City
Quilmes
State/Province
Buenos Aires
ZIP/Postal Code
B1878FNR
Country
Argentina
Facility Name
GSK Investigational Site
City
San Isidro
State/Province
Buenos Aires
ZIP/Postal Code
B1642DCD
Country
Argentina
Facility Name
GSK Investigational Site
City
San Martin
State/Province
Buenos Aires
ZIP/Postal Code
1650
Country
Argentina
Facility Name
GSK Investigational Site
City
San Nicolas
State/Province
Buenos Aires
ZIP/Postal Code
B2900DMH
Country
Argentina
Facility Name
GSK Investigational Site
City
San Nicolas
State/Province
Buenos Aires
ZIP/Postal Code
B2900IIC
Country
Argentina
Facility Name
GSK Investigational Site
City
Vicente López
State/Province
Buenos Aires
ZIP/Postal Code
1602
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
State/Province
Córdova
ZIP/Postal Code
X5000AAW
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
State/Province
Córdova
ZIP/Postal Code
X5003DCE
Country
Argentina
Facility Name
GSK Investigational Site
City
Concepcion del Uruguay
State/Province
Entre Ríos
ZIP/Postal Code
3260
Country
Argentina
Facility Name
GSK Investigational Site
City
Parana
State/Province
Entre Ríos
ZIP/Postal Code
E3100BHK
Country
Argentina
Facility Name
GSK Investigational Site
City
Godoy Cruz
State/Province
Mendoza
ZIP/Postal Code
5501
Country
Argentina
Facility Name
GSK Investigational Site
City
Cipoletti, Rio Negro
State/Province
Río Negro
ZIP/Postal Code
R8324CVE
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
2000
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
S2000BIF
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
S2000CVD
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
S2002OJN
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
S2005PAF
Country
Argentina
Facility Name
GSK Investigational Site
City
Tucuman
State/Province
Tucumán
ZIP/Postal Code
4000
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
B1704ETD
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1061ABD
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1120AAC
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1280AEB
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1407HUF
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1425AGC
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1425FVH
Country
Argentina
Facility Name
GSK Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1437BZ
Country
Argentina
Facility Name
GSK Investigational Site
City
Ciudad Autonoma de Buenos Aires
ZIP/Postal Code
C1425BEN
Country
Argentina
Facility Name
GSK Investigational Site
City
Ciudad Autónoma de Buenos Aires
ZIP/Postal Code
C1426ABP
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
ZIP/Postal Code
5000
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
ZIP/Postal Code
5016
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
ZIP/Postal Code
5900
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
ZIP/Postal Code
X5003DCE
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
ZIP/Postal Code
X5004BAL
Country
Argentina
Facility Name
GSK Investigational Site
City
Cordoba
ZIP/Postal Code
X5006
Country
Argentina
Facility Name
GSK Investigational Site
City
Coronel Suarez
ZIP/Postal Code
7540
Country
Argentina
Facility Name
GSK Investigational Site
City
Corrientes
ZIP/Postal Code
W3400AVK
Country
Argentina
Facility Name
GSK Investigational Site
City
Florencio Varela
ZIP/Postal Code
C1073ABA
Country
Argentina
Facility Name
GSK Investigational Site
City
Formosa
ZIP/Postal Code
3600
Country
Argentina
Facility Name
GSK Investigational Site
City
Jujuy
ZIP/Postal Code
4600
Country
Argentina
Facility Name
GSK Investigational Site
City
Lanús
ZIP/Postal Code
B1824KAJ
Country
Argentina
Facility Name
GSK Investigational Site
City
Mar del Plata
ZIP/Postal Code
B7600FYK
Country
Argentina
Facility Name
GSK Investigational Site
City
Mendoza
ZIP/Postal Code
5500
Country
Argentina
Facility Name
GSK Investigational Site
City
Mendoza
ZIP/Postal Code
M5500CCG
Country
Argentina
Facility Name
GSK Investigational Site
City
Mendoza
ZIP/Postal Code
MM5500
Country
Argentina
Facility Name
GSK Investigational Site
City
Monte Grande
ZIP/Postal Code
1842
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
ZIP/Postal Code
2000
Country
Argentina
Facility Name
GSK Investigational Site
City
Rosario
ZIP/Postal Code
S2000CXP
Country
Argentina
Facility Name
GSK Investigational Site
City
Salta
ZIP/Postal Code
A4400ANG
Country
Argentina
Facility Name
GSK Investigational Site
City
Salta
ZIP/Postal Code
A4400ERH
Country
Argentina
Facility Name
GSK Investigational Site
City
San Luis
ZIP/Postal Code
5700
Country
Argentina
Facility Name
GSK Investigational Site
City
San Miguel de Tucuman
ZIP/Postal Code
4000
Country
Argentina
Facility Name
GSK Investigational Site
City
San Miguel de Tucumán
ZIP/Postal Code
4000
Country
Argentina
Facility Name
GSK Investigational Site
City
Santa Fe
ZIP/Postal Code
3000
Country
Argentina
Facility Name
GSK Investigational Site
City
Santa Fe
ZIP/Postal Code
3016
Country
Argentina
Facility Name
GSK Investigational Site
City
Santiago del Estero
Country
Argentina
Facility Name
GSK Investigational Site
City
Cairns
State/Province
Queensland
ZIP/Postal Code
4870
Country
Australia
Facility Name
GSK Investigational Site
City
Redcliffe
State/Province
Queensland
ZIP/Postal Code
4020
Country
Australia
Facility Name
GSK Investigational Site
City
Bedford Park
State/Province
South Australia
ZIP/Postal Code
5042
Country
Australia
Facility Name
GSK Investigational Site
City
Daw Park
State/Province
South Australia
ZIP/Postal Code
5041
Country
Australia
Facility Name
GSK Investigational Site
City
Footscray
State/Province
Victoria
ZIP/Postal Code
3011
Country
Australia
Facility Name
GSK Investigational Site
City
Geelong
State/Province
Victoria
ZIP/Postal Code
3220
Country
Australia
Facility Name
GSK Investigational Site
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3004
Country
Australia
Facility Name
GSK Investigational Site
City
Glen Osmond
ZIP/Postal Code
5064
Country
Australia
Facility Name
GSK Investigational Site
City
Feldbach
ZIP/Postal Code
8330
Country
Austria
Facility Name
GSK Investigational Site
City
Feldkirch
ZIP/Postal Code
6800
Country
Austria
Facility Name
GSK Investigational Site
City
Grieskirchen
ZIP/Postal Code
A-4710
Country
Austria
Facility Name
GSK Investigational Site
City
Innsbruck
ZIP/Postal Code
A-6020
Country
Austria
Facility Name
GSK Investigational Site
City
Linz
ZIP/Postal Code
4020
Country
Austria
Facility Name
GSK Investigational Site
City
Salzburg
ZIP/Postal Code
5020
Country
Austria
Facility Name
GSK Investigational Site
City
Salzburg
ZIP/Postal Code
A-5020
Country
Austria
Facility Name
GSK Investigational Site
City
Spittal/Drau
ZIP/Postal Code
9800
Country
Austria
Facility Name
GSK Investigational Site
City
Thalheim bei Wels
ZIP/Postal Code
4600
Country
Austria
Facility Name
GSK Investigational Site
City
Vienna
ZIP/Postal Code
A-1120
Country
Austria
Facility Name
GSK Investigational Site
City
Wels
ZIP/Postal Code
4600
Country
Austria
Facility Name
GSK Investigational Site
City
Zwettl
ZIP/Postal Code
3910
Country
Austria
Facility Name
GSK Investigational Site
City
Brest
ZIP/Postal Code
224027
Country
Belarus
Facility Name
GSK Investigational Site
City
Gomel
ZIP/Postal Code
246040
Country
Belarus
Facility Name
GSK Investigational Site
City
Grodno
ZIP/Postal Code
230017
Country
Belarus
Facility Name
GSK Investigational Site
City
Minsk
ZIP/Postal Code
220030
Country
Belarus
Facility Name
GSK Investigational Site
City
Minsk
ZIP/Postal Code
220053
Country
Belarus
Facility Name
GSK Investigational Site
City
Minsk
ZIP/Postal Code
223041
Country
Belarus
Facility Name
GSK Investigational Site
City
Vitebsk
ZIP/Postal Code
210037
Country
Belarus
Facility Name
GSK Investigational Site
City
Diest
ZIP/Postal Code
3290
Country
Belgium
Facility Name
GSK Investigational Site
City
Erpent
ZIP/Postal Code
5101
Country
Belgium
Facility Name
GSK Investigational Site
City
Gilly
ZIP/Postal Code
6060
Country
Belgium
Facility Name
GSK Investigational Site
City
Mons
ZIP/Postal Code
7000
Country
Belgium
Facility Name
GSK Investigational Site
City
Namur
ZIP/Postal Code
5000
Country
Belgium
Facility Name
GSK Investigational Site
City
Banja Luka
ZIP/Postal Code
78000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Banjaluka
ZIP/Postal Code
78000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Bihac
ZIP/Postal Code
77 000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Bihac
ZIP/Postal Code
77000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Bijeljina
ZIP/Postal Code
76300
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Brcko
ZIP/Postal Code
76000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Foca
ZIP/Postal Code
73300
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Gracanica
ZIP/Postal Code
75320
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Gradiska
ZIP/Postal Code
78400
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Istocno Sarajevo
ZIP/Postal Code
71123
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Konjic
ZIP/Postal Code
88400
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Mostar
ZIP/Postal Code
88000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Novi Travnik
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Pale
ZIP/Postal Code
71420
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Sarajevo
ZIP/Postal Code
71000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Sarajevo
ZIP/Postal Code
71320
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Srebrenik
ZIP/Postal Code
75350
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Tesanj
ZIP/Postal Code
74260
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Teslić
ZIP/Postal Code
74270
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Travnik
ZIP/Postal Code
72270
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Trebinje
ZIP/Postal Code
89101
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Tuzla
ZIP/Postal Code
75000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Visegrad
ZIP/Postal Code
73240
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Zenica
ZIP/Postal Code
72000
Country
Bosnia and Herzegovina
Facility Name
GSK Investigational Site
City
Blagoevgrad
ZIP/Postal Code
2700
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Dimitrovgrad
ZIP/Postal Code
6400
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Gabrovo
ZIP/Postal Code
5300
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Kozlodui
ZIP/Postal Code
3320
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Lovech
ZIP/Postal Code
5500
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Pazardjik
ZIP/Postal Code
4400
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Petrich
ZIP/Postal Code
2850
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Pleven
ZIP/Postal Code
5800
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Plovdiv
ZIP/Postal Code
4002
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Razgrad
ZIP/Postal Code
7200
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Rousse
ZIP/Postal Code
7000
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sevlievo
ZIP/Postal Code
5400
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sliven
ZIP/Postal Code
8800
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1000
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1142
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1202
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1233
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1336
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1431
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1505
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1606
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1618
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Sofia
ZIP/Postal Code
1784
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Stara Zagora
ZIP/Postal Code
6000
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Stara Zagora
ZIP/Postal Code
6003
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Troyan
ZIP/Postal Code
5600
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Varna
ZIP/Postal Code
9000
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Veliko Tarnovo
ZIP/Postal Code
5000
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Vidin
ZIP/Postal Code
3700
Country
Bulgaria
Facility Name
GSK Investigational Site
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5A 4L8
Country
Canada
Facility Name
GSK Investigational Site
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5J 3S9
Country
Canada
Facility Name
GSK Investigational Site
City
Kamloops
State/Province
British Columbia
ZIP/Postal Code
V2C 1K7
Country
Canada
Facility Name
GSK Investigational Site
City
Penticton
State/Province
British Columbia
ZIP/Postal Code
V2A 5C8
Country
Canada
Facility Name
GSK Investigational Site
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z 4E1
Country
Canada
Facility Name
GSK Investigational Site
City
West Vancouver
State/Province
British Columbia
ZIP/Postal Code
V7T 2Z3
Country
Canada
Facility Name
GSK Investigational Site
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3H 2A6
Country
Canada
Facility Name
GSK Investigational Site
City
Bolton
State/Province
Ontario
ZIP/Postal Code
L7E 4C8
Country
Canada
Facility Name
GSK Investigational Site
City
Burlington
State/Province
Ontario
ZIP/Postal Code
L7N 3V2
Country
Canada
Facility Name
GSK Investigational Site
City
Grimsby
State/Province
Ontario
ZIP/Postal Code
L3M 1P3
Country
Canada
Facility Name
GSK Investigational Site
City
London
State/Province
Ontario
ZIP/Postal Code
N5Y 5K7
Country
Canada
Facility Name
GSK Investigational Site
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L4T 4J2
Country
Canada
Facility Name
GSK Investigational Site
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L5M 2V8
Country
Canada
Facility Name
GSK Investigational Site
City
Newmarket
State/Province
Ontario
ZIP/Postal Code
L3Y 5G8
Country
Canada
Facility Name
GSK Investigational Site
City
Orleans
State/Province
Ontario
ZIP/Postal Code
K4A 5E6
Country
Canada
Facility Name
GSK Investigational Site
City
Sarnia
State/Province
Ontario
ZIP/Postal Code
N7T 4X3
Country
Canada
Facility Name
GSK Investigational Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5T 3A9
Country
Canada
Facility Name
GSK Investigational Site
City
Windsor
State/Province
Ontario
ZIP/Postal Code
N8X 5A6
Country
Canada
Facility Name
GSK Investigational Site
City
Mirabel
State/Province
Quebec
ZIP/Postal Code
J7J 2K8
Country
Canada
Facility Name
GSK Investigational Site
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H2W1T8
Country
Canada
Facility Name
GSK Investigational Site
City
Sainte Jerome
State/Province
Quebec
ZIP/Postal Code
J7Z 5T3
Country
Canada
Facility Name
GSK Investigational Site
City
Quebec
ZIP/Postal Code
G1G 4A2
Country
Canada
Facility Name
GSK Investigational Site
City
Temuco
State/Province
Región De La Araucania
ZIP/Postal Code
4800798
Country
Chile
Facility Name
GSK Investigational Site
City
Temuco
State/Province
Región De La Araucania
Country
Chile
Facility Name
GSK Investigational Site
City
Santiago
State/Province
Región Metro De Santiago
ZIP/Postal Code
7500691
Country
Chile
Facility Name
GSK Investigational Site
City
Santiago
State/Province
Región Metro De Santiago
ZIP/Postal Code
8910131
Country
Chile
Facility Name
GSK Investigational Site
City
Santiago
State/Province
Región Metro De Santiago
Country
Chile
Facility Name
GSK Investigational Site
City
Viña del Mar
State/Province
Valparaíso
ZIP/Postal Code
2340000
Country
Chile
Facility Name
GSK Investigational Site
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510080
Country
China
Facility Name
GSK Investigational Site
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510120
Country
China
Facility Name
GSK Investigational Site
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510515
Country
China
Facility Name
GSK Investigational Site
City
Shenzhen
State/Province
Guangdong
ZIP/Postal Code
518020
Country
China
Facility Name
GSK Investigational Site
City
Zhanjiang
State/Province
Guangdong
ZIP/Postal Code
524001
Country
China
Facility Name
GSK Investigational Site
City
Nanning
State/Province
Guangxi
ZIP/Postal Code
530021
Country
China
Facility Name
GSK Investigational Site
City
Haikou
State/Province
Hainan
ZIP/Postal Code
570001
Country
China
Facility Name
GSK Investigational Site
City
Haikou
State/Province
Hainan
ZIP/Postal Code
570311
Country
China
Facility Name
GSK Investigational Site
City
Hohhot
State/Province
Hainan
ZIP/Postal Code
010050
Country
China
Facility Name
GSK Investigational Site
City
Shijiazhuang
State/Province
Hebei
ZIP/Postal Code
050000
Country
China
Facility Name
GSK Investigational Site
City
Wuhan
State/Province
Hubei
ZIP/Postal Code
430060
Country
China
Facility Name
GSK Investigational Site
City
Baotou
State/Province
Inner Mongolia
ZIP/Postal Code
014010
Country
China
Facility Name
GSK Investigational Site
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110004
Country
China
Facility Name
GSK Investigational Site
City
Yinchuan
State/Province
Ningxia
ZIP/Postal Code
750004
Country
China
Facility Name
GSK Investigational Site
City
Xian
State/Province
Shaanxi
ZIP/Postal Code
710032
Country
China
Facility Name
GSK Investigational Site
City
Jinan
State/Province
Shandong
ZIP/Postal Code
250033
Country
China
Facility Name
GSK Investigational Site
City
Taiyuan
State/Province
Shanxi
ZIP/Postal Code
030001
Country
China
Facility Name
GSK Investigational Site
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610083
Country
China
Facility Name
GSK Investigational Site
City
Baotou
Country
China
Facility Name
GSK Investigational Site
City
Beijing
ZIP/Postal Code
100020
Country
China
Facility Name
GSK Investigational Site
City
Beijing
ZIP/Postal Code
100029
Country
China
Facility Name
GSK Investigational Site
City
Beijing
ZIP/Postal Code
100050
Country
China
Facility Name
GSK Investigational Site
City
Beijing
ZIP/Postal Code
100070
Country
China
Facility Name
GSK Investigational Site
City
Beijing
ZIP/Postal Code
100144
Country
China
Facility Name
GSK Investigational Site
City
Bengbu
ZIP/Postal Code
233000
Country
China
Facility Name
GSK Investigational Site
City
Changchun
ZIP/Postal Code
130012
Country
China
Facility Name
GSK Investigational Site
City
Chengdu
ZIP/Postal Code
610041
Country
China
Facility Name
GSK Investigational Site
City
Chongqing
ZIP/Postal Code
400016
Country
China
Facility Name
GSK Investigational Site
City
Chongqing
ZIP/Postal Code
400038
Country
China
Facility Name
GSK Investigational Site
City
Chongqing
ZIP/Postal Code
400042
Country
China
Facility Name
GSK Investigational Site
City
Fu Zhou
Country
China
Facility Name
GSK Investigational Site
City
Fuzhou
ZIP/Postal Code
350025
Country
China
Facility Name
GSK Investigational Site
City
Guangxi
ZIP/Postal Code
530021
Country
China
Facility Name
GSK Investigational Site
City
Guangzhou
ZIP/Postal Code
510080
Country
China
Facility Name
GSK Investigational Site
City
Hangzhou
ZIP/Postal Code
310014
Country
China
Facility Name
GSK Investigational Site
City
Hefei
ZIP/Postal Code
230001
Country
China
Facility Name
GSK Investigational Site
City
Huai'an
ZIP/Postal Code
223300
Country
China
Facility Name
GSK Investigational Site
City
Jiangyin
Country
China
Facility Name
GSK Investigational Site
City
Luzhou
Country
China
Facility Name
GSK Investigational Site
City
Nanchang
ZIP/Postal Code
330006
Country
China
Facility Name
GSK Investigational Site
City
Nanjing
ZIP/Postal Code
210009
Country
China
Facility Name
GSK Investigational Site
City
Shanghai
ZIP/Postal Code
200003
Country
China
Facility Name
GSK Investigational Site
City
Shanghai
ZIP/Postal Code
200025
Country
China
Facility Name
GSK Investigational Site
City
Shanghai
ZIP/Postal Code
200032
Country
China
Facility Name
GSK Investigational Site
City
Shanghai
ZIP/Postal Code
200040
Country
China
Facility Name
GSK Investigational Site
City
ShangHai
ZIP/Postal Code
200062
Country
China
Facility Name
GSK Investigational Site
City
Shanghai
ZIP/Postal Code
200072
Country
China
Facility Name
GSK Investigational Site
City
Shanghai
ZIP/Postal Code
200433
Country
China
Facility Name
GSK Investigational Site
City
Tianjin
ZIP/Postal Code
300121
Country
China
Facility Name
GSK Investigational Site
City
Wuxi
ZIP/Postal Code
214023
Country
China
Facility Name
GSK Investigational Site
City
Barranquilla
Country
Colombia
Facility Name
GSK Investigational Site
City
Bogota
ZIP/Postal Code
111211
Country
Colombia
Facility Name
GSK Investigational Site
City
Bogota
Country
Colombia
Facility Name
GSK Investigational Site
City
Bogotá
ZIP/Postal Code
80CO
Country
Colombia
Facility Name
GSK Investigational Site
City
Bogotá
Country
Colombia
Facility Name
GSK Investigational Site
City
Cali
ZIP/Postal Code
571
Country
Colombia
Facility Name
GSK Investigational Site
City
Medellin
ZIP/Postal Code
80372
Country
Colombia
Facility Name
GSK Investigational Site
City
Medellin
Country
Colombia
Facility Name
GSK Investigational Site
City
Zipaquira
Country
Colombia
Facility Name
GSK Investigational Site
City
Cakovec
ZIP/Postal Code
40000
Country
Croatia
Facility Name
GSK Investigational Site
City
Draganic
ZIP/Postal Code
47201
Country
Croatia
Facility Name
GSK Investigational Site
City
Hrasce Turopoljsko
ZIP/Postal Code
10020
Country
Croatia
Facility Name
GSK Investigational Site
City
Hreljin
ZIP/Postal Code
51226
Country
Croatia
Facility Name
GSK Investigational Site
City
Ivankovo
ZIP/Postal Code
32281
Country
Croatia
Facility Name
GSK Investigational Site
City
Karlovac
ZIP/Postal Code
47000
Country
Croatia
Facility Name
GSK Investigational Site
City
Klenovnik
ZIP/Postal Code
42244
Country
Croatia
Facility Name
GSK Investigational Site
City
Krapina
ZIP/Postal Code
49000
Country
Croatia
Facility Name
GSK Investigational Site
City
Kutina
ZIP/Postal Code
44320
Country
Croatia
Facility Name
GSK Investigational Site
City
Novi Marof
ZIP/Postal Code
42220
Country
Croatia
Facility Name
GSK Investigational Site
City
Osijek
ZIP/Postal Code
31000
Country
Croatia
Facility Name
GSK Investigational Site
City
Retkovci
ZIP/Postal Code
32282
Country
Croatia
Facility Name
GSK Investigational Site
City
Rijeka
ZIP/Postal Code
51000
Country
Croatia
Facility Name
GSK Investigational Site
City
Samobor
ZIP/Postal Code
10430
Country
Croatia
Facility Name
GSK Investigational Site
City
Senj
ZIP/Postal Code
53270
Country
Croatia
Facility Name
GSK Investigational Site
City
Sibenik
ZIP/Postal Code
22000
Country
Croatia
Facility Name
GSK Investigational Site
City
Sisak
ZIP/Postal Code
44000
Country
Croatia
Facility Name
GSK Investigational Site
City
Split
ZIP/Postal Code
21000
Country
Croatia
Facility Name
GSK Investigational Site
City
Strmec Samoborski
ZIP/Postal Code
10434
Country
Croatia
Facility Name
GSK Investigational Site
City
Stubicke toplice
ZIP/Postal Code
49244
Country
Croatia
Facility Name
GSK Investigational Site
City
Sukosan
ZIP/Postal Code
23206
Country
Croatia
Facility Name
GSK Investigational Site
City
Varazdin
ZIP/Postal Code
42000
Country
Croatia
Facility Name
GSK Investigational Site
City
Zabok
ZIP/Postal Code
49210
Country
Croatia
Facility Name
GSK Investigational Site
City
Zadar
ZIP/Postal Code
23000
Country
Croatia
Facility Name
GSK Investigational Site
City
Zagreb
ZIP/Postal Code
10000
Country
Croatia
Facility Name
GSK Investigational Site
City
Benesov
ZIP/Postal Code
256 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Beroun
ZIP/Postal Code
266 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Brno
ZIP/Postal Code
612 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Havlickuv brod
ZIP/Postal Code
580 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Hlucin
ZIP/Postal Code
748 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Holesov
ZIP/Postal Code
769 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Jaromer
ZIP/Postal Code
551 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Jindrichuv Hradec
ZIP/Postal Code
377 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Kolin
ZIP/Postal Code
280 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Kralupy nad Vltavou
ZIP/Postal Code
278 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Kromeriz
ZIP/Postal Code
767 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Liberec
ZIP/Postal Code
460 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Melnik
ZIP/Postal Code
276 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Moravsky Krumlov
ZIP/Postal Code
672 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Neratovice
ZIP/Postal Code
277 11
Country
Czechia
Facility Name
GSK Investigational Site
City
Novy Jicin
ZIP/Postal Code
741 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Ostrava - Belsky les
ZIP/Postal Code
700 30
Country
Czechia
Facility Name
GSK Investigational Site
City
Ostrava - Poruba
ZIP/Postal Code
70868
Country
Czechia
Facility Name
GSK Investigational Site
City
Ostrava
ZIP/Postal Code
72880
Country
Czechia
Facility Name
GSK Investigational Site
City
Plzen
ZIP/Postal Code
301 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Plzen
ZIP/Postal Code
323 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 13
ZIP/Postal Code
158 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 17
ZIP/Postal Code
163 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 1
ZIP/Postal Code
110 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 3
ZIP/Postal Code
130 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 4
ZIP/Postal Code
140 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 4
ZIP/Postal Code
140 46
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 5
ZIP/Postal Code
150 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Praha 6
ZIP/Postal Code
169 00
Country
Czechia
Facility Name
GSK Investigational Site
City
Rokycany
ZIP/Postal Code
337 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Rudna
ZIP/Postal Code
252 19
Country
Czechia
Facility Name
GSK Investigational Site
City
Strakonice
ZIP/Postal Code
386 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Strakonice
ZIP/Postal Code
386 29
Country
Czechia
Facility Name
GSK Investigational Site
City
Svitavy
ZIP/Postal Code
568 25
Country
Czechia
Facility Name
GSK Investigational Site
City
Tremosna
ZIP/Postal Code
330 11
Country
Czechia
Facility Name
GSK Investigational Site
City
Usti Nad Labem - Klise
ZIP/Postal Code
400 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Zatec
ZIP/Postal Code
438 01
Country
Czechia
Facility Name
GSK Investigational Site
City
Ferolles Attilly
ZIP/Postal Code
77150
Country
France
Facility Name
GSK Investigational Site
City
Paris Cedex 04
ZIP/Postal Code
75181
Country
France
Facility Name
GSK Investigational Site
City
Strasbourg Cedex
ZIP/Postal Code
67091
Country
France
Facility Name
GSK Investigational Site
City
Tarbes
ZIP/Postal Code
65013
Country
France
Facility Name
GSK Investigational Site
City
Toulouse cedex 9
ZIP/Postal Code
31059
Country
France
Facility Name
GSK Investigational Site
City
Batumi
ZIP/Postal Code
6000
Country
Georgia
Facility Name
GSK Investigational Site
City
Gurjaani
ZIP/Postal Code
1500
Country
Georgia
Facility Name
GSK Investigational Site
City
Kutaisi
ZIP/Postal Code
1600
Country
Georgia
Facility Name
GSK Investigational Site
City
Kvemo Kartli
ZIP/Postal Code
3000
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0101
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0102
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0114
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0141
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0144
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0160
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0177
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0186
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
ZIP/Postal Code
0191
Country
Georgia
Facility Name
GSK Investigational Site
City
Tbilisi
Country
Georgia
Facility Name
GSK Investigational Site
City
Bruchsal
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
76646
Country
Germany
Facility Name
GSK Investigational Site
City
Deggingen
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
73326
Country
Germany
Facility Name
GSK Investigational Site
City
Ettlingen
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
76275
Country
Germany
Facility Name
GSK Investigational Site
City
Frankfurt
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
60596
Country
Germany
Facility Name
GSK Investigational Site
City
Karlsruhe
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
76227
Country
Germany
Facility Name
GSK Investigational Site
City
Aschaffenburg
State/Province
Bayern
ZIP/Postal Code
63739
Country
Germany
Facility Name
GSK Investigational Site
City
Augsburg
State/Province
Bayern
ZIP/Postal Code
86150
Country
Germany
Facility Name
GSK Investigational Site
City
Augsburg
State/Province
Bayern
ZIP/Postal Code
86156
Country
Germany
Facility Name
GSK Investigational Site
City
Bad Woerrishofen
State/Province
Bayern
ZIP/Postal Code
86825
Country
Germany
Facility Name
GSK Investigational Site
City
Feldkirchen
State/Province
Bayern
ZIP/Postal Code
83620
Country
Germany
Facility Name
GSK Investigational Site
City
Fuerth
State/Province
Bayern
ZIP/Postal Code
90762
Country
Germany
Facility Name
GSK Investigational Site
City
Gauting
State/Province
Bayern
ZIP/Postal Code
82131
Country
Germany
Facility Name
GSK Investigational Site
City
Hoechstadt
State/Province
Bayern
ZIP/Postal Code
91315
Country
Germany
Facility Name
GSK Investigational Site
City
Landsberg
State/Province
Bayern
ZIP/Postal Code
86899
Country
Germany
Facility Name
GSK Investigational Site
City
Muenchen
State/Province
Bayern
ZIP/Postal Code
80335
Country
Germany
Facility Name
GSK Investigational Site
City
Vilshofen
State/Province
Bayern
ZIP/Postal Code
94474
Country
Germany
Facility Name
GSK Investigational Site
City
Weissenhorn
State/Province
Bayern
ZIP/Postal Code
89264
Country
Germany
Facility Name
GSK Investigational Site
City
Cottbus
State/Province
Brandenburg
ZIP/Postal Code
03050
Country
Germany
Facility Name
GSK Investigational Site
City
Potsdam
State/Province
Brandenburg
ZIP/Postal Code
14478
Country
Germany
Facility Name
GSK Investigational Site
City
Ruedersdorf
State/Province
Brandenburg
ZIP/Postal Code
15562
Country
Germany
Facility Name
GSK Investigational Site
City
Bensheim
State/Province
Hessen
ZIP/Postal Code
64625
Country
Germany
Facility Name
GSK Investigational Site
City
Darmstadt
State/Province
Hessen
ZIP/Postal Code
64287
Country
Germany
Facility Name
GSK Investigational Site
City
Kassel
State/Province
Hessen
ZIP/Postal Code
34121
Country
Germany
Facility Name
GSK Investigational Site
City
Marburg
State/Province
Hessen
ZIP/Postal Code
35037
Country
Germany
Facility Name
GSK Investigational Site
City
Goettingen
State/Province
Niedersachsen
ZIP/Postal Code
37081
Country
Germany
Facility Name
GSK Investigational Site
City
Hannover
State/Province
Niedersachsen
ZIP/Postal Code
30159
Country
Germany
Facility Name
GSK Investigational Site
City
Papenburg
State/Province
Niedersachsen
ZIP/Postal Code
26871
Country
Germany
Facility Name
GSK Investigational Site
City
Stuhr
State/Province
Niedersachsen
ZIP/Postal Code
28816
Country
Germany
Facility Name
GSK Investigational Site
City
Wardenburg
State/Province
Niedersachsen
ZIP/Postal Code
26203
Country
Germany
Facility Name
GSK Investigational Site
City
Bergisch Gladbach
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
51429
Country
Germany
Facility Name
GSK Investigational Site
City
Bochum
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
44787
Country
Germany
Facility Name
GSK Investigational Site
City
Bonn
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
53119
Country
Germany
Facility Name
GSK Investigational Site
City
Bonn
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
53123
Country
Germany
Facility Name
GSK Investigational Site
City
Dortmund
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
44263
Country
Germany
Facility Name
GSK Investigational Site
City
Dueren
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
52349
Country
Germany
Facility Name
GSK Investigational Site
City
Essen
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
45136
Country
Germany
Facility Name
GSK Investigational Site
City
Essen
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
45355
Country
Germany
Facility Name
GSK Investigational Site
City
Gelsenkirchen
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
45879
Country
Germany
Facility Name
GSK Investigational Site
City
Hagen
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
58089
Country
Germany
Facility Name
GSK Investigational Site
City
Hagen
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
58095
Country
Germany
Facility Name
GSK Investigational Site
City
Harsewinkel
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
33428
Country
Germany
Facility Name
GSK Investigational Site
City
Koeln
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
51069
Country
Germany
Facility Name
GSK Investigational Site
City
Neuss
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
41462
Country
Germany
Facility Name
GSK Investigational Site
City
Solingen
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
42651
Country
Germany
Facility Name
GSK Investigational Site
City
Foehren
State/Province
Rheinland-Pfalz
ZIP/Postal Code
54343
Country
Germany
Facility Name
GSK Investigational Site
City
Ingelheim
State/Province
Rheinland-Pfalz
ZIP/Postal Code
55218
Country
Germany
Facility Name
GSK Investigational Site
City
Mainz
State/Province
Rheinland-Pfalz
ZIP/Postal Code
55116
Country
Germany
Facility Name
GSK Investigational Site
City
Neuwied
State/Province
Rheinland-Pfalz
ZIP/Postal Code
56564
Country
Germany
Facility Name
GSK Investigational Site
City
Rhaunen
State/Province
Rheinland-Pfalz
ZIP/Postal Code
55624
Country
Germany
Facility Name
GSK Investigational Site
City
Magdeburg
State/Province
Sachsen-Anhalt
ZIP/Postal Code
39104
Country
Germany
Facility Name
GSK Investigational Site
City
Zerbst
State/Province
Sachsen-Anhalt
ZIP/Postal Code
39261
Country
Germany
Facility Name
GSK Investigational Site
City
Dresden
State/Province
Sachsen
ZIP/Postal Code
01067
Country
Germany
Facility Name
GSK Investigational Site
City
Dresden
State/Province
Sachsen
ZIP/Postal Code
01307
Country
Germany
Facility Name
GSK Investigational Site
City
Goerlitz
State/Province
Sachsen
ZIP/Postal Code
02826
Country
Germany
Facility Name
GSK Investigational Site
City
Leipzg
State/Province
Sachsen
ZIP/Postal Code
04109
Country
Germany
Facility Name
GSK Investigational Site
City
Leipzig
State/Province
Sachsen
ZIP/Postal Code
04103
Country
Germany
Facility Name
GSK Investigational Site
City
Leipzig
State/Province
Sachsen
ZIP/Postal Code
04157
Country
Germany
Facility Name
GSK Investigational Site
City
Leipzig
State/Province
Sachsen
ZIP/Postal Code
04275
Country
Germany
Facility Name
GSK Investigational Site
City
Leipzig
State/Province
Sachsen
ZIP/Postal Code
04357
Country
Germany
Facility Name
GSK Investigational Site
City
Riesa
State/Province
Sachsen
ZIP/Postal Code
01587
Country
Germany
Facility Name
GSK Investigational Site
City
Reinfeld
State/Province
Schleswig-Holstein
ZIP/Postal Code
23858
Country
Germany
Facility Name
GSK Investigational Site
City
Schleswig
State/Province
Schleswig-Holstein
ZIP/Postal Code
24837
Country
Germany
Facility Name
GSK Investigational Site
City
Jena
State/Province
Thueringen
ZIP/Postal Code
07740
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
10717
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
10787
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
10789
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
10969
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
12043
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
12099
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
12165
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
12203
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
12627
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
12687
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
13086
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
13125
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
13156
Country
Germany
Facility Name
GSK Investigational Site
City
Berlin
ZIP/Postal Code
13507
Country
Germany
Facility Name
GSK Investigational Site
City
Hamburg
ZIP/Postal Code
22291
Country
Germany
Facility Name
GSK Investigational Site
City
Hamburg
ZIP/Postal Code
22763
Country
Germany
Facility Name
GSK Investigational Site
City
München
ZIP/Postal Code
81677
Country
Germany
Facility Name
GSK Investigational Site
City
Athens
ZIP/Postal Code
11527
Country
Greece
Facility Name
GSK Investigational Site
City
Athens
ZIP/Postal Code
15126
Country
Greece
Facility Name
GSK Investigational Site
City
Thessaloniki
ZIP/Postal Code
57010
Country
Greece
Facility Name
GSK Investigational Site
City
Balassagyarmat
ZIP/Postal Code
2660
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1036
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1101
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1117
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1122
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1125
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1134
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1191
Country
Hungary
Facility Name
GSK Investigational Site
City
Budapest
ZIP/Postal Code
1204
Country
Hungary
Facility Name
GSK Investigational Site
City
Debrecen
ZIP/Postal Code
4026
Country
Hungary
Facility Name
GSK Investigational Site
City
Debrecen
ZIP/Postal Code
4031
Country
Hungary
Facility Name
GSK Investigational Site
City
Gyula
ZIP/Postal Code
5703
Country
Hungary
Facility Name
GSK Investigational Site
City
Kaposvár
ZIP/Postal Code
7400
Country
Hungary
Facility Name
GSK Investigational Site
City
Komarom
ZIP/Postal Code
2900
Country
Hungary
Facility Name
GSK Investigational Site
City
Komló
ZIP/Postal Code
7300
Country
Hungary
Facility Name
GSK Investigational Site
City
Mosonmagyaróvár
ZIP/Postal Code
9200
Country
Hungary
Facility Name
GSK Investigational Site
City
Nagykanizsa
ZIP/Postal Code
8800
Country
Hungary
Facility Name
GSK Investigational Site
City
Nyiregyhaza
ZIP/Postal Code
4400
Country
Hungary
Facility Name
GSK Investigational Site
City
Pécs
ZIP/Postal Code
7635
Country
Hungary
Facility Name
GSK Investigational Site
City
Sopron
ZIP/Postal Code
9400
Country
Hungary
Facility Name
GSK Investigational Site
City
Szigetszentmiklos
ZIP/Postal Code
2310
Country
Hungary
Facility Name
GSK Investigational Site
City
Szikszó
ZIP/Postal Code
H-3800
Country
Hungary
Facility Name
GSK Investigational Site
City
Szombathely
ZIP/Postal Code
9700
Country
Hungary
Facility Name
GSK Investigational Site
City
Tatabanya
ZIP/Postal Code
2800
Country
Hungary
Facility Name
GSK Investigational Site
City
Vasarosnameny
ZIP/Postal Code
4800
Country
Hungary
Facility Name
GSK Investigational Site
City
Zalaegerszeg
ZIP/Postal Code
8900
Country
Hungary
Facility Name
GSK Investigational Site
City
Ahmedabad
ZIP/Postal Code
380007
Country
India
Facility Name
GSK Investigational Site
City
Ahmedabad
ZIP/Postal Code
380052
Country
India
Facility Name
GSK Investigational Site
City
Alappuzha
ZIP/Postal Code
688524
Country
India
Facility Name
GSK Investigational Site
City
Angamaly
ZIP/Postal Code
683 572
Country
India
Facility Name
GSK Investigational Site
City
Aurangabad
ZIP/Postal Code
431001
Country
India
Facility Name
GSK Investigational Site
City
Bangalore
ZIP/Postal Code
560 010
Country
India
Facility Name
GSK Investigational Site
City
Bangalore
ZIP/Postal Code
560 054
Country
India
Facility Name
GSK Investigational Site
City
Bangalore
ZIP/Postal Code
560034
Country
India
Facility Name
GSK Investigational Site
City
Bangalore
ZIP/Postal Code
560076
Country
India
Facility Name
GSK Investigational Site
City
Chennai
ZIP/Postal Code
600034
Country
India
Facility Name
GSK Investigational Site
City
Chennai
ZIP/Postal Code
600100
Country
India
Facility Name
GSK Investigational Site
City
Guntur
ZIP/Postal Code
522001
Country
India
Facility Name
GSK Investigational Site
City
Hyderabad
ZIP/Postal Code
500004
Country
India
Facility Name
GSK Investigational Site
City
Hyderabad
ZIP/Postal Code
500035
Country
India
Facility Name
GSK Investigational Site
City
Hyderabad
ZIP/Postal Code
500038
Country
India
Facility Name
GSK Investigational Site
City
Jaipur
ZIP/Postal Code
302006
Country
India
Facility Name
GSK Investigational Site
City
Jaipur
ZIP/Postal Code
302022
Country
India
Facility Name
GSK Investigational Site
City
Lucknow
ZIP/Postal Code
226018
Country
India
Facility Name
GSK Investigational Site
City
Mysore
ZIP/Postal Code
570002
Country
India
Facility Name
GSK Investigational Site
City
Mysore
ZIP/Postal Code
570004
Country
India
Facility Name
GSK Investigational Site
City
Nagpur
ZIP/Postal Code
440012
Country
India
Facility Name
GSK Investigational Site
City
Nagpur
ZIP/Postal Code
440019
Country
India
Facility Name
GSK Investigational Site
City
Nashik
ZIP/Postal Code
422007
Country
India
Facility Name
GSK Investigational Site
City
Nasik
ZIP/Postal Code
422005
Country
India
Facility Name
GSK Investigational Site
City
Pune
ZIP/Postal Code
411014
Country
India
Facility Name
GSK Investigational Site
City
Pune
ZIP/Postal Code
411015
Country
India
Facility Name
GSK Investigational Site
City
Trisshur
ZIP/Postal Code
680 002
Country
India
Facility Name
GSK Investigational Site
City
Trivandrum
ZIP/Postal Code
695004
Country
India
Facility Name
GSK Investigational Site
City
Varanasi
ZIP/Postal Code
221001
Country
India
Facility Name
GSK Investigational Site
City
Varanasi
ZIP/Postal Code
221005
Country
India
Facility Name
GSK Investigational Site
City
Vijayawada
ZIP/Postal Code
520002
Country
India
Facility Name
GSK Investigational Site
City
Banda Aceh
ZIP/Postal Code
23126
Country
Indonesia
Facility Name
GSK Investigational Site
City
Banjarmasin
ZIP/Postal Code
70233
Country
Indonesia
Facility Name
GSK Investigational Site
City
Bukittinggi
ZIP/Postal Code
26117
Country
Indonesia
Facility Name
GSK Investigational Site
City
Denpasar
ZIP/Postal Code
80114
Country
Indonesia
Facility Name
GSK Investigational Site
City
Depok Timur
ZIP/Postal Code
16411
Country
Indonesia
Facility Name
GSK Investigational Site
City
Jakarta
ZIP/Postal Code
12430
Country
Indonesia
Facility Name
GSK Investigational Site
City
Jakarta
ZIP/Postal Code
13230
Country
Indonesia
Facility Name
GSK Investigational Site
City
Jakarta
ZIP/Postal Code
13630
Country
Indonesia
Facility Name
GSK Investigational Site
City
Lampung Selatan
ZIP/Postal Code
35373
Country
Indonesia
Facility Name
GSK Investigational Site
City
Makassar
ZIP/Postal Code
90245
Country
Indonesia
Facility Name
GSK Investigational Site
City
Malang
ZIP/Postal Code
65100
Country
Indonesia
Facility Name
GSK Investigational Site
City
Medan
ZIP/Postal Code
20111
Country
Indonesia
Facility Name
GSK Investigational Site
City
Medan
ZIP/Postal Code
20154
Country
Indonesia
Facility Name
GSK Investigational Site
City
Padang
ZIP/Postal Code
25127
Country
Indonesia
Facility Name
GSK Investigational Site
City
Palembang
ZIP/Postal Code
30126
Country
Indonesia
Facility Name
GSK Investigational Site
City
Pekanbaru
ZIP/Postal Code
28133
Country
Indonesia
Facility Name
GSK Investigational Site
City
Pontianak
ZIP/Postal Code
78122
Country
Indonesia
Facility Name
GSK Investigational Site
City
Pringsewu
ZIP/Postal Code
35373
Country
Indonesia
Facility Name
GSK Investigational Site
City
Semarang
ZIP/Postal Code
50242
Country
Indonesia
Facility Name
GSK Investigational Site
City
Surabaya
ZIP/Postal Code
60286
Country
Indonesia
Facility Name
GSK Investigational Site
City
Surakarta
ZIP/Postal Code
57126
Country
Indonesia
Facility Name
GSK Investigational Site
City
Yogyakarta
ZIP/Postal Code
55283
Country
Indonesia
Facility Name
GSK Investigational Site
City
Afula
ZIP/Postal Code
18101
Country
Israel
Facility Name
GSK Investigational Site
City
Ashkelon
ZIP/Postal Code
78306
Country
Israel
Facility Name
GSK Investigational Site
City
Beer-Sheba
ZIP/Postal Code
84101
Country
Israel
Facility Name
GSK Investigational Site
City
Hadera
ZIP/Postal Code
PO Box 169
Country
Israel
Facility Name
GSK Investigational Site
City
Haifa
ZIP/Postal Code
31096
Country
Israel
Facility Name
GSK Investigational Site
City
Haifa
ZIP/Postal Code
34362
Country
Israel
Facility Name
GSK Investigational Site
City
Holon
ZIP/Postal Code
68125
Country
Israel
Facility Name
GSK Investigational Site
City
Jerusalem
ZIP/Postal Code
91120
Country
Israel
Facility Name
GSK Investigational Site
City
Kfar Saba
ZIP/Postal Code
44281
Country
Israel
Facility Name
GSK Investigational Site
City
Rehovot
ZIP/Postal Code
76100
Country
Israel
Facility Name
GSK Investigational Site
City
Tel Aviv
ZIP/Postal Code
64239
Country
Israel
Facility Name
GSK Investigational Site
City
Tel Hashomer
ZIP/Postal Code
52621
Country
Israel
Facility Name
GSK Investigational Site
City
Pordenone
State/Province
Friuli-Venezia-Giulia
ZIP/Postal Code
33170
Country
Italy
Facility Name
GSK Investigational Site
City
Aichi
ZIP/Postal Code
454-8502
Country
Japan
Facility Name
GSK Investigational Site
City
Aichi
ZIP/Postal Code
457-8510
Country
Japan
Facility Name
GSK Investigational Site
City
Aichi
ZIP/Postal Code
457-8511
Country
Japan
Facility Name
GSK Investigational Site
City
Fukuoka
ZIP/Postal Code
832-0059
Country
Japan
Facility Name
GSK Investigational Site
City
Gifu
ZIP/Postal Code
500-8717
Country
Japan
Facility Name
GSK Investigational Site
City
Hokkaido
ZIP/Postal Code
053-8506
Country
Japan
Facility Name
GSK Investigational Site
City
Hokkaido
ZIP/Postal Code
060-0033
Country
Japan
Facility Name
GSK Investigational Site
City
Hokkaido
ZIP/Postal Code
070-8644
Country
Japan
Facility Name
GSK Investigational Site
City
Hyogo
ZIP/Postal Code
650-0047
Country
Japan
Facility Name
GSK Investigational Site
City
Ibaraki
ZIP/Postal Code
319-1113
Country
Japan
Facility Name
GSK Investigational Site
City
Kagawa
ZIP/Postal Code
762-0031
Country
Japan
Facility Name
GSK Investigational Site
City
Kodaira
ZIP/Postal Code
187-0002
Country
Japan
Facility Name
GSK Investigational Site
City
Kumamoto
ZIP/Postal Code
861-1196
Country
Japan
Facility Name
GSK Investigational Site
City
Kyoto
ZIP/Postal Code
607-8062
Country
Japan
Facility Name
GSK Investigational Site
City
Oita
ZIP/Postal Code
876-0047
Country
Japan
Facility Name
GSK Investigational Site
City
Osaka
ZIP/Postal Code
530-0001
Country
Japan
Facility Name
GSK Investigational Site
City
Osaka
ZIP/Postal Code
558-8558
Country
Japan
Facility Name
GSK Investigational Site
City
Osaka
ZIP/Postal Code
591-8555
Country
Japan
Facility Name
GSK Investigational Site
City
Shimane
ZIP/Postal Code
690-8509
Country
Japan
Facility Name
GSK Investigational Site
City
Shimane
ZIP/Postal Code
690-8556
Country
Japan
Facility Name
GSK Investigational Site
City
Tokyo
ZIP/Postal Code
103-0027
Country
Japan
Facility Name
GSK Investigational Site
City
Tokyo
ZIP/Postal Code
103-0028
Country
Japan
Facility Name
GSK Investigational Site
City
Tokyo
ZIP/Postal Code
194-0023
Country
Japan
Facility Name
GSK Investigational Site
City
Bucheon-Si, Gyeonggi-Do
ZIP/Postal Code
420-021
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Bucheon
ZIP/Postal Code
420-717
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Busan
ZIP/Postal Code
602-715
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Cheonan
ZIP/Postal Code
330-721
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Chonju-si
ZIP/Postal Code
561-712
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Daegu
ZIP/Postal Code
705-717
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Daejeon
ZIP/Postal Code
301-721
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Daejeon
ZIP/Postal Code
301-723
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Goyang-si
ZIP/Postal Code
411706
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Guri-si
ZIP/Postal Code
471-701
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Gwangju
ZIP/Postal Code
501-757
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Gyeonggi-do
ZIP/Postal Code
410-719
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Incheon
ZIP/Postal Code
400-711
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Incheon
ZIP/Postal Code
403-720
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Kangwon
ZIP/Postal Code
200-722
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seongnam
ZIP/Postal Code
463-712
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
100-030
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
110-746
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
130-709
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
130-872
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
133--792
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
135-720
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
136-705
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
139-707
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
139-711
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
140-887
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
150-713
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
152-703
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
158-710
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
ZIP/Postal Code
380-704
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Seoul
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Suwon, Gyeonggi-do
ZIP/Postal Code
442-723
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Uijeongbu, Gyeonggi-do
ZIP/Postal Code
480-717
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Ulsan
ZIP/Postal Code
682-714
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Wonju-si, Kanwon-do
ZIP/Postal Code
220-701
Country
Korea, Republic of
Facility Name
GSK Investigational Site
City
Balvi
ZIP/Postal Code
LV - 4501
Country
Latvia
Facility Name
GSK Investigational Site
City
Daugavpils
ZIP/Postal Code
LA-5403
Country
Latvia
Facility Name
GSK Investigational Site
City
Daugavpils
ZIP/Postal Code
LV5410
Country
Latvia
Facility Name
GSK Investigational Site
City
Jekabpils
ZIP/Postal Code
LV 5201
Country
Latvia
Facility Name
GSK Investigational Site
City
Jelgava
ZIP/Postal Code
LV - 3001
Country
Latvia
Facility Name
GSK Investigational Site
City
Jurmala
ZIP/Postal Code
LV-2010
Country
Latvia
Facility Name
GSK Investigational Site
City
Kraslava
ZIP/Postal Code
LV - 5601
Country
Latvia
Facility Name
GSK Investigational Site
City
Kuldiga
ZIP/Postal Code
LV - 3301
Country
Latvia
Facility Name
GSK Investigational Site
City
Liepaja
ZIP/Postal Code
LV 3414
Country
Latvia
Facility Name
GSK Investigational Site
City
Ogre
ZIP/Postal Code
LV - 5001
Country
Latvia
Facility Name
GSK Investigational Site
City
Riga
ZIP/Postal Code
LV 1002
Country
Latvia
Facility Name
GSK Investigational Site
City
Riga
ZIP/Postal Code
LV 1003
Country
Latvia
Facility Name
GSK Investigational Site
City
Riga
ZIP/Postal Code
LV-1010
Country
Latvia
Facility Name
GSK Investigational Site
City
Riga
ZIP/Postal Code
LV1001
Country
Latvia
Facility Name
GSK Investigational Site
City
Riga
ZIP/Postal Code
LV1038
Country
Latvia
Facility Name
GSK Investigational Site
City
Talsi
ZIP/Postal Code
LV - 3201
Country
Latvia
Facility Name
GSK Investigational Site
City
Tukums
ZIP/Postal Code
LV - 3101
Country
Latvia
Facility Name
GSK Investigational Site
City
Valmiera
ZIP/Postal Code
LV-4201
Country
Latvia
Facility Name
GSK Investigational Site
City
Ventspils
ZIP/Postal Code
LV3601
Country
Latvia
Facility Name
GSK Investigational Site
City
Bitola
ZIP/Postal Code
7000
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Gostivar
ZIP/Postal Code
1230
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Ohrid
ZIP/Postal Code
6000
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Prilep
ZIP/Postal Code
7500
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Shtip
ZIP/Postal Code
2000
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Skopje
ZIP/Postal Code
1000
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Strumica
ZIP/Postal Code
2400
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Veles
ZIP/Postal Code
1400
Country
Macedonia, The Former Yugoslav Republic of
Facility Name
GSK Investigational Site
City
Johor Bahru
ZIP/Postal Code
80100
Country
Malaysia
Facility Name
GSK Investigational Site
City
Kuala Lumpur
ZIP/Postal Code
50590
Country
Malaysia
Facility Name
GSK Investigational Site
City
Kuala Pilah
ZIP/Postal Code
72000
Country
Malaysia
Facility Name
GSK Investigational Site
City
Kuching
ZIP/Postal Code
93586
Country
Malaysia
Facility Name
GSK Investigational Site
City
Selangor
ZIP/Postal Code
68100
Country
Malaysia
Facility Name
GSK Investigational Site
City
Sibu
ZIP/Postal Code
96000
Country
Malaysia
Facility Name
GSK Investigational Site
City
Sungai Petani, Kedah
ZIP/Postal Code
08000
Country
Malaysia
Facility Name
GSK Investigational Site
City
Taiping Perak
ZIP/Postal Code
34000
Country
Malaysia
Facility Name
GSK Investigational Site
City
Cuautitlan Izcalli
State/Province
Estado De México
ZIP/Postal Code
54769
Country
Mexico
Facility Name
GSK Investigational Site
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44500
Country
Mexico
Facility Name
GSK Investigational Site
City
Zapopan
State/Province
Jalisco
ZIP/Postal Code
45040
Country
Mexico
Facility Name
GSK Investigational Site
City
Morelia
State/Province
Michoacán
ZIP/Postal Code
C.P. 58249
Country
Mexico
Facility Name
GSK Investigational Site
City
Cuernavaca
State/Province
Morelos
ZIP/Postal Code
62350
Country
Mexico
Facility Name
GSK Investigational Site
City
Monterrey
State/Province
Nuevo León
ZIP/Postal Code
64460
Country
Mexico
Facility Name
GSK Investigational Site
City
Monterrey
State/Province
Nuevo León
ZIP/Postal Code
64710
Country
Mexico
Facility Name
GSK Investigational Site
City
Hermosillo
State/Province
Sonora
ZIP/Postal Code
83000
Country
Mexico
Facility Name
GSK Investigational Site
City
Aguascalientes
ZIP/Postal Code
20127
Country
Mexico
Facility Name
GSK Investigational Site
City
Chihuahua
ZIP/Postal Code
31203
Country
Mexico
Facility Name
GSK Investigational Site
City
Chihuahua
ZIP/Postal Code
31238
Country
Mexico
Facility Name
GSK Investigational Site
City
Guadalajara
ZIP/Postal Code
44670
Country
Mexico
Facility Name
GSK Investigational Site
City
Hidalgo
ZIP/Postal Code
42070
Country
Mexico
Facility Name
GSK Investigational Site
City
Merida
ZIP/Postal Code
97000
Country
Mexico
Facility Name
GSK Investigational Site
City
Mexico D.F
ZIP/Postal Code
6700
Country
Mexico
Facility Name
GSK Investigational Site
City
Monterrey
ZIP/Postal Code
64060
Country
Mexico
Facility Name
GSK Investigational Site
City
México DF
ZIP/Postal Code
14050
Country
Mexico
Facility Name
GSK Investigational Site
City
San luis Potosí
ZIP/Postal Code
78090
Country
Mexico
Facility Name
GSK Investigational Site
City
Alkmaar
ZIP/Postal Code
1815 JD
Country
Netherlands
Facility Name
GSK Investigational Site
City
Almelo
ZIP/Postal Code
7609 PP
Country
Netherlands
Facility Name
GSK Investigational Site
City
Ede Gld
ZIP/Postal Code
6717RP
Country
Netherlands
Facility Name
GSK Investigational Site
City
Helmond
ZIP/Postal Code
5707 HA
Country
Netherlands
Facility Name
GSK Investigational Site
City
Zutphen
ZIP/Postal Code
7207 AE
Country
Netherlands
Facility Name
GSK Investigational Site
City
Alabang, Muntinlupa City
ZIP/Postal Code
1780
Country
Philippines
Facility Name
GSK Investigational Site
City
Caloocan
ZIP/Postal Code
1400
Country
Philippines
Facility Name
GSK Investigational Site
City
Cavite
ZIP/Postal Code
4114
Country
Philippines
Facility Name
GSK Investigational Site
City
Cebu City
ZIP/Postal Code
6000
Country
Philippines
Facility Name
GSK Investigational Site
City
Dasmariñas, Cavite
ZIP/Postal Code
4114
Country
Philippines
Facility Name
GSK Investigational Site
City
Davao
ZIP/Postal Code
8000
Country
Philippines
Facility Name
GSK Investigational Site
City
Iloilo City
ZIP/Postal Code
5000
Country
Philippines
Facility Name
GSK Investigational Site
City
Iloilo
ZIP/Postal Code
5000
Country
Philippines
Facility Name
GSK Investigational Site
City
Jaro, Iloilo City
ZIP/Postal Code
5000
Country
Philippines
Facility Name
GSK Investigational Site
City
Los Banos
ZIP/Postal Code
4030
Country
Philippines
Facility Name
GSK Investigational Site
City
Manila
ZIP/Postal Code
1000
Country
Philippines
Facility Name
GSK Investigational Site
City
Manila
ZIP/Postal Code
1012
Country
Philippines
Facility Name
GSK Investigational Site
City
Marilao, Bulacan
ZIP/Postal Code
3019
Country
Philippines
Facility Name
GSK Investigational Site
City
Pasay
ZIP/Postal Code
1300
Country
Philippines
Facility Name
GSK Investigational Site
City
Pasig
ZIP/Postal Code
1605
Country
Philippines
Facility Name
GSK Investigational Site
City
Quezon City
ZIP/Postal Code
1100
Country
Philippines
Facility Name
GSK Investigational Site
City
Quezon City
ZIP/Postal Code
1102
Country
Philippines
Facility Name
GSK Investigational Site
City
Quezon City
ZIP/Postal Code
1108
Country
Philippines
Facility Name
GSK Investigational Site
City
Quezon City
ZIP/Postal Code
1109
Country
Philippines
Facility Name
GSK Investigational Site
City
Quezon
ZIP/Postal Code
1104
Country
Philippines
Facility Name
GSK Investigational Site
City
San Fernando, Pampanga
ZIP/Postal Code
2000
Country
Philippines
Facility Name
GSK Investigational Site
City
Bialystok
ZIP/Postal Code
15-003
Country
Poland
Facility Name
GSK Investigational Site
City
Bialystok
ZIP/Postal Code
15-044
Country
Poland
Facility Name
GSK Investigational Site
City
Bielsko-Biala
ZIP/Postal Code
43-300
Country
Poland
Facility Name
GSK Investigational Site
City
Bielsko-Biala
ZIP/Postal Code
43-316
Country
Poland
Facility Name
GSK Investigational Site
City
Bienkowka
ZIP/Postal Code
34-212
Country
Poland
Facility Name
GSK Investigational Site
City
Bydgoszcz
ZIP/Postal Code
85-681
Country
Poland
Facility Name
GSK Investigational Site
City
Bydgoszcz
ZIP/Postal Code
85-863
Country
Poland
Facility Name
GSK Investigational Site
City
Chelmza
ZIP/Postal Code
87-140
Country
Poland
Facility Name
GSK Investigational Site
City
Chodziez
ZIP/Postal Code
64-800
Country
Poland
Facility Name
GSK Investigational Site
City
Chorzow
ZIP/Postal Code
41-500
Country
Poland
Facility Name
GSK Investigational Site
City
Choszczno
ZIP/Postal Code
73-200
Country
Poland
Facility Name
GSK Investigational Site
City
Czestochowa
ZIP/Postal Code
42-200
Country
Poland
Facility Name
GSK Investigational Site
City
Dabrowa Gornicza
ZIP/Postal Code
41-300
Country
Poland
Facility Name
GSK Investigational Site
City
Dzialdowo
ZIP/Postal Code
13-200
Country
Poland
Facility Name
GSK Investigational Site
City
Elblag
ZIP/Postal Code
82-300
Country
Poland
Facility Name
GSK Investigational Site
City
Gdansk
ZIP/Postal Code
80-286
Country
Poland
Facility Name
GSK Investigational Site
City
Gdansk
ZIP/Postal Code
80-405
Country
Poland
Facility Name
GSK Investigational Site
City
Gdansk
ZIP/Postal Code
80-433
Country
Poland
Facility Name
GSK Investigational Site
City
Gdynia
ZIP/Postal Code
81-384
Country
Poland
Facility Name
GSK Investigational Site
City
Gorzow Wielkopolski
ZIP/Postal Code
66-400
Country
Poland
Facility Name
GSK Investigational Site
City
Grudziadz
ZIP/Postal Code
86-300
Country
Poland
Facility Name
GSK Investigational Site
City
Ilawa
ZIP/Postal Code
14-200
Country
Poland
Facility Name
GSK Investigational Site
City
Inowroclaw
ZIP/Postal Code
88-100
Country
Poland
Facility Name
GSK Investigational Site
City
Izabelin
ZIP/Postal Code
05-080
Country
Poland
Facility Name
GSK Investigational Site
City
Jelenia Gora
ZIP/Postal Code
58-506
Country
Poland
Facility Name
GSK Investigational Site
City
Karpacz
ZIP/Postal Code
58-540
Country
Poland
Facility Name
GSK Investigational Site
City
Katowice
ZIP/Postal Code
40-040
Country
Poland
Facility Name
GSK Investigational Site
City
Katowice
ZIP/Postal Code
40-954
Country
Poland
Facility Name
GSK Investigational Site
City
Kielce
ZIP/Postal Code
25-030
Country
Poland
Facility Name
GSK Investigational Site
City
Kielce
ZIP/Postal Code
25-365
Country
Poland
Facility Name
GSK Investigational Site
City
Kielce
ZIP/Postal Code
25-734
Country
Poland
Facility Name
GSK Investigational Site
City
Krakow
ZIP/Postal Code
31-024
Country
Poland
Facility Name
GSK Investigational Site
City
Krakow
ZIP/Postal Code
31-455
Country
Poland
Facility Name
GSK Investigational Site
City
Krakow
ZIP/Postal Code
31-530
Country
Poland
Facility Name
GSK Investigational Site
City
Krakow
ZIP/Postal Code
31-567
Country
Poland
Facility Name
GSK Investigational Site
City
Krakow
ZIP/Postal Code
31-637
Country
Poland
Facility Name
GSK Investigational Site
City
Krakow
ZIP/Postal Code
31-913
Country
Poland
Facility Name
GSK Investigational Site
City
Krotoszyn
ZIP/Postal Code
63-700
Country
Poland
Facility Name
GSK Investigational Site
City
Ksawerow
ZIP/Postal Code
95-054
Country
Poland
Facility Name
GSK Investigational Site
City
Kutno
ZIP/Postal Code
99-300
Country
Poland
Facility Name
GSK Investigational Site
City
Libiaz
ZIP/Postal Code
32-590
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
90-153
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
90-203
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
90-302
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
90-430
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
91-849
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
92-107
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
92-215
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
93-113
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
93-329
Country
Poland
Facility Name
GSK Investigational Site
City
Lodz
ZIP/Postal Code
94-050
Country
Poland
Facility Name
GSK Investigational Site
City
Lublin
ZIP/Postal Code
20-093
Country
Poland
Facility Name
GSK Investigational Site
City
Lublin
ZIP/Postal Code
20-552
Country
Poland
Facility Name
GSK Investigational Site
City
Lublin
ZIP/Postal Code
20-718
Country
Poland
Facility Name
GSK Investigational Site
City
Olawa
ZIP/Postal Code
55-200
Country
Poland
Facility Name
GSK Investigational Site
City
Olsztyn
ZIP/Postal Code
10-357
Country
Poland
Facility Name
GSK Investigational Site
City
Ostrow Wilekopolski
ZIP/Postal Code
63-400
Country
Poland
Facility Name
GSK Investigational Site
City
Ostrowiec Swietokrzyski
ZIP/Postal Code
27-400
Country
Poland
Facility Name
GSK Investigational Site
City
Piaseczno
ZIP/Postal Code
05-500
Country
Poland
Facility Name
GSK Investigational Site
City
Pila
ZIP/Postal Code
64-920
Country
Poland
Facility Name
GSK Investigational Site
City
Plock
ZIP/Postal Code
09-402
Country
Poland
Facility Name
GSK Investigational Site
City
Police
ZIP/Postal Code
72-010
Country
Poland
Facility Name
GSK Investigational Site
City
Poznan
ZIP/Postal Code
60-214
Country
Poland
Facility Name
GSK Investigational Site
City
Poznan
ZIP/Postal Code
60-569
Country
Poland
Facility Name
GSK Investigational Site
City
Poznan
ZIP/Postal Code
60-773
Country
Poland
Facility Name
GSK Investigational Site
City
Poznan
ZIP/Postal Code
60-823
Country
Poland
Facility Name
GSK Investigational Site
City
Ruda Slaska
ZIP/Postal Code
41-709
Country
Poland
Facility Name
GSK Investigational Site
City
Rudka
ZIP/Postal Code
05-320
Country
Poland
Facility Name
GSK Investigational Site
City
Rzeszow
ZIP/Postal Code
35-301
Country
Poland
Facility Name
GSK Investigational Site
City
Skarzysko-Kamienna
ZIP/Postal Code
26-110
Country
Poland
Facility Name
GSK Investigational Site
City
Skierniewice
ZIP/Postal Code
96-100
Country
Poland
Facility Name
GSK Investigational Site
City
Slupsk
ZIP/Postal Code
76-200
Country
Poland
Facility Name
GSK Investigational Site
City
Sopot
ZIP/Postal Code
81- 717
Country
Poland
Facility Name
GSK Investigational Site
City
Swidnik
ZIP/Postal Code
21-040
Country
Poland
Facility Name
GSK Investigational Site
City
Szczecin
ZIP/Postal Code
70-111
Country
Poland
Facility Name
GSK Investigational Site
City
Szczecin
ZIP/Postal Code
71-124
Country
Poland
Facility Name
GSK Investigational Site
City
Tarnow
ZIP/Postal Code
33-100
Country
Poland
Facility Name
GSK Investigational Site
City
Tczew
ZIP/Postal Code
83-110
Country
Poland
Facility Name
GSK Investigational Site
City
Torun
ZIP/Postal Code
87100
Country
Poland
Facility Name
GSK Investigational Site
City
Warszawa
ZIP/Postal Code
01-138
Country
Poland
Facility Name
GSK Investigational Site
City
Warszawa
ZIP/Postal Code
01-157
Country
Poland
Facility Name
GSK Investigational Site
City
Warszawa
ZIP/Postal Code
01-192
Country
Poland
Facility Name
GSK Investigational Site
City
Warszawa
ZIP/Postal Code
01-868
Country
Poland
Facility Name
GSK Investigational Site
City
Wloclawek
ZIP/Postal Code
87-800
Country
Poland
Facility Name
GSK Investigational Site
City
Wloszczowa
ZIP/Postal Code
29-100
Country
Poland
Facility Name
GSK Investigational Site
City
Wodzislaw Slaski
ZIP/Postal Code
44-300
Country
Poland
Facility Name
GSK Investigational Site
City
Wroclaw
ZIP/Postal Code
50-044
Country
Poland
Facility Name
GSK Investigational Site
City
Wroclaw
ZIP/Postal Code
50-088
Country
Poland
Facility Name
GSK Investigational Site
City
Wroclaw
ZIP/Postal Code
53-301
Country
Poland
Facility Name
GSK Investigational Site
City
Wroclaw
ZIP/Postal Code
53-439
Country
Poland
Facility Name
GSK Investigational Site
City
Wroclaw
ZIP/Postal Code
54-239
Country
Poland
Facility Name
GSK Investigational Site
City
Zabrze
ZIP/Postal Code
41-800
Country
Poland
Facility Name
GSK Investigational Site
City
Zabrze
ZIP/Postal Code
41-807
Country
Poland
Facility Name
GSK Investigational Site
City
Zgierz
ZIP/Postal Code
95-100
Country
Poland
Facility Name
GSK Investigational Site
City
Łęczyca
ZIP/Postal Code
99-100
Country
Poland
Facility Name
GSK Investigational Site
City
Arad
ZIP/Postal Code
310013
Country
Romania
Facility Name
GSK Investigational Site
City
Bacau
ZIP/Postal Code
600252
Country
Romania
Facility Name
GSK Investigational Site
City
Bragadiru
ZIP/Postal Code
077025
Country
Romania
Facility Name
GSK Investigational Site
City
Brasov
ZIP/Postal Code
500086
Country
Romania
Facility Name
GSK Investigational Site
City
Brasov
ZIP/Postal Code
500283
Country
Romania
Facility Name
GSK Investigational Site
City
Bucarest
ZIP/Postal Code
050159
Country
Romania
Facility Name
GSK Investigational Site
City
Bucharest
ZIP/Postal Code
011794
Country
Romania
Facility Name
GSK Investigational Site
City
Bucharest
ZIP/Postal Code
020125
Country
Romania
Facility Name
GSK Investigational Site
City
Bucharest
ZIP/Postal Code
030303
Country
Romania
Facility Name
GSK Investigational Site
City
Bucharest
ZIP/Postal Code
050159
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
011025
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
012384
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
014461
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
020475
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
021659
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
022328
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
030303
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
040206
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
050159
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
050554
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
050722
Country
Romania
Facility Name
GSK Investigational Site
City
Bucuresti
ZIP/Postal Code
10825
Country
Romania
Facility Name
GSK Investigational Site
City
Campulung Muscel
ZIP/Postal Code
115100
Country
Romania
Facility Name
GSK Investigational Site
City
Cluj-Napoca
ZIP/Postal Code
400352
Country
Romania
Facility Name
GSK Investigational Site
City
Cluj-Napoca
ZIP/Postal Code
400371
Country
Romania
Facility Name
GSK Investigational Site
City
Codlea
ZIP/Postal Code
505100
Country
Romania
Facility Name
GSK Investigational Site
City
Constanta
ZIP/Postal Code
900002
Country
Romania
Facility Name
GSK Investigational Site
City
Constanta
ZIP/Postal Code
900004
Country
Romania
Facility Name
GSK Investigational Site
City
Deva
ZIP/Postal Code
330084
Country
Romania
Facility Name
GSK Investigational Site
City
Iasi
ZIP/Postal Code
700141
Country
Romania
Facility Name
GSK Investigational Site
City
Iasi
ZIP/Postal Code
700381
Country
Romania
Facility Name
GSK Investigational Site
City
Iasi
ZIP/Postal Code
700503
Country
Romania
Facility Name
GSK Investigational Site
City
Iasi
ZIP/Postal Code
700656
Country
Romania
Facility Name
GSK Investigational Site
City
Pitesti
ZIP/Postal Code
110084
Country
Romania
Facility Name
GSK Investigational Site
City
Pitesti
ZIP/Postal Code
110283
Country
Romania
Facility Name
GSK Investigational Site
City
Ploiesti
ZIP/Postal Code
100184
Country
Romania
Facility Name
GSK Investigational Site
City
Ramnicu Valcea
ZIP/Postal Code
240564
Country
Romania
Facility Name
GSK Investigational Site
City
Suceava
ZIP/Postal Code
720284
Country
Romania
Facility Name
GSK Investigational Site
City
Targu-Mures
ZIP/Postal Code
540142
Country
Romania
Facility Name
GSK Investigational Site
City
Timisoara
ZIP/Postal Code
300310
Country
Romania
Facility Name
GSK Investigational Site
City
Timisoara
ZIP/Postal Code
300736
Country
Romania
Facility Name
GSK Investigational Site
City
Arkhangelsk
ZIP/Postal Code
163001
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Arkhangelsk
ZIP/Postal Code
163061
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Barnaul
ZIP/Postal Code
656024
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Barnaul
ZIP/Postal Code
656038
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Chelyabinsk
ZIP/Postal Code
454021
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Chelyabinsk
ZIP/Postal Code
454047
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Chelyabinsk
ZIP/Postal Code
454091
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ekaterinburg
ZIP/Postal Code
620109
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ekaterinburg
ZIP/Postal Code
620137
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ekaterinburg
ZIP/Postal Code
620149
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Gatchina
ZIP/Postal Code
188300
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ivanovo
ZIP/Postal Code
153462
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Izhevsk
ZIP/Postal Code
426063
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Kaliningrad
ZIP/Postal Code
236016
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Kazan
ZIP/Postal Code
420012
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Kemerovo
ZIP/Postal Code
650000
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Kemerovo
ZIP/Postal Code
650002
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Kirov
ZIP/Postal Code
610027
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Krasnoyarsk
ZIP/Postal Code
660022
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Kursk
ZIP/Postal Code
305035
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
105066
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
107392
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
109263
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
111111
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
111539
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
115 280
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
115093
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
115432
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
115478
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
115516
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
115682
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
117292
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
117593
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
117630
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
117997
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119002
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119048
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119049
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119121
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119229
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119620
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
119991
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
121 309
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
121374
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
123060
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
123182
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
125205
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
125299
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
127018
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
129090
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Moscow
ZIP/Postal Code
129301
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Nizhniy Novgorod
ZIP/Postal Code
603035
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
ZIP/Postal Code
630008
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
ZIP/Postal Code
630051
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
ZIP/Postal Code
630075
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
ZIP/Postal Code
630087
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
ZIP/Postal Code
630091
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
ZIP/Postal Code
630099
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Novosibirsk
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Orenburg
ZIP/Postal Code
460000
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Orenburg
ZIP/Postal Code
460018
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Perm
ZIP/Postal Code
614070
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Perm
ZIP/Postal Code
614097
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Perm
ZIP/Postal Code
614111
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Pskov
ZIP/Postal Code
180016
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Rostov-on-Don
ZIP/Postal Code
344022
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ryazan
ZIP/Postal Code
390005
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ryazan
ZIP/Postal Code
390026
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ryazan
ZIP/Postal Code
390039
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint Petersburg
ZIP/Postal Code
192177
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint Petersburg
ZIP/Postal Code
194044
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint Petersburg
ZIP/Postal Code
195257
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint Petersburg
ZIP/Postal Code
196084
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint Petersburg
ZIP/Postal Code
197022
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint Petersburg
ZIP/Postal Code
198103
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint-Petersburg
ZIP/Postal Code
194354
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint-Petersburg
ZIP/Postal Code
195112
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint-Petersburg
ZIP/Postal Code
196084
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint-Petersburg
ZIP/Postal Code
196601
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint-Petersburg
ZIP/Postal Code
198260
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saint-Petersburg
ZIP/Postal Code
198328
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saratov
ZIP/Postal Code
410012
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saratov
ZIP/Postal Code
410018
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saratov
ZIP/Postal Code
410028
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saratov
ZIP/Postal Code
410039
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Saratov
ZIP/Postal Code
410054
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Sestroretsk
ZIP/Postal Code
197706
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Smolensk
ZIP/Postal Code
214 019
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Smolensk
ZIP/Postal Code
214006
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St Petersburg
ZIP/Postal Code
192283
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St Petersburg
ZIP/Postal Code
194354
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St'Petersburg
ZIP/Postal Code
193312
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St-Petersburg
ZIP/Postal Code
193312
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St-Petersburg
ZIP/Postal Code
194017
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St-Petersburg
ZIP/Postal Code
199106
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St. Petersburg
ZIP/Postal Code
190103
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St. Petersburg
ZIP/Postal Code
191015
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St. Petersburg
ZIP/Postal Code
194356
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St. Petersburg
ZIP/Postal Code
197022
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St.Petersburg
ZIP/Postal Code
191025
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St.Petersburg
ZIP/Postal Code
197089
Country
Russian Federation
Facility Name
GSK Investigational Site
City
St.Рetersburg
ZIP/Postal Code
198035
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Tomsk
ZIP/Postal Code
634 050
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Tomsk
ZIP/Postal Code
634012
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Tomsk
ZIP/Postal Code
634050
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Tomsk
ZIP/Postal Code
634063
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Tver
ZIP/Postal Code
170036
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ufa
ZIP/Postal Code
450071
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Ulyanovsk
ZIP/Postal Code
432063
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Voronezh
ZIP/Postal Code
394018
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Voronezh
ZIP/Postal Code
394066
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Vsevolzhsk
ZIP/Postal Code
188640
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Yaroslavl
ZIP/Postal Code
150002
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Yaroslavl
ZIP/Postal Code
150003
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Yaroslavl
ZIP/Postal Code
150010
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Yaroslavl
ZIP/Postal Code
150023
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Yaroslavl
ZIP/Postal Code
150062
Country
Russian Federation
Facility Name
GSK Investigational Site
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Facility Name
GSK Investigational Site
City
Belgrade
ZIP/Postal Code
11080
Country
Serbia
Facility Name
GSK Investigational Site
City
Cacak
ZIP/Postal Code
32000
Country
Serbia
Facility Name
GSK Investigational Site
City
Kragujevac
ZIP/Postal Code
34000
Country
Serbia
Facility Name
GSK Investigational Site
City
Nis
ZIP/Postal Code
18000
Country
Serbia
Facility Name
GSK Investigational Site
City
Sombor
ZIP/Postal Code
25000
Country
Serbia
Facility Name
GSK Investigational Site
City
Sremska Kamenica
ZIP/Postal Code
21204
Country
Serbia
Facility Name
GSK Investigational Site
City
Valjevo
ZIP/Postal Code
14000
Country
Serbia
Facility Name
GSK Investigational Site
City
Bratislava
ZIP/Postal Code
821 06
Country
Slovakia
Facility Name
GSK Investigational Site
City
Bratislava
ZIP/Postal Code
841 04
Country
Slovakia
Facility Name
GSK Investigational Site
City
Bratislava
ZIP/Postal Code
841 08
Country
Slovakia
Facility Name
GSK Investigational Site
City
Bratislava
ZIP/Postal Code
851 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Kosice
ZIP/Postal Code
040 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Kralovsky Chlmec
ZIP/Postal Code
077 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Nove Zamky
ZIP/Postal Code
940 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Presov
ZIP/Postal Code
080 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Presov
ZIP/Postal Code
081 81
Country
Slovakia
Facility Name
GSK Investigational Site
City
Spisska Nova Ves
ZIP/Postal Code
052 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Sturovo
ZIP/Postal Code
943 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Trnava
ZIP/Postal Code
917 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Vrable
ZIP/Postal Code
952 01
Country
Slovakia
Facility Name
GSK Investigational Site
City
Benoni
State/Province
Gauteng
ZIP/Postal Code
1501
Country
South Africa
Facility Name
GSK Investigational Site
City
Boksburg
State/Province
Gauteng
ZIP/Postal Code
1459
Country
South Africa
Facility Name
GSK Investigational Site
City
Meyerspark
State/Province
Gauteng
ZIP/Postal Code
0184
Country
South Africa
Facility Name
GSK Investigational Site
City
Morningside
State/Province
Gauteng
ZIP/Postal Code
2057
Country
South Africa
Facility Name
GSK Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0041
Country
South Africa
Facility Name
GSK Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0084
Country
South Africa
Facility Name
GSK Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0181
Country
South Africa
Facility Name
GSK Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0183
Country
South Africa
Facility Name
GSK Investigational Site
City
Thaba Tshwane
State/Province
Gauteng
ZIP/Postal Code
0143
Country
South Africa
Facility Name
GSK Investigational Site
City
Dundee
State/Province
KwaZulu- Natal
ZIP/Postal Code
3000
Country
South Africa
Facility Name
GSK Investigational Site
City
Middelburg
State/Province
Mpumalanga
ZIP/Postal Code
1055
Country
South Africa
Facility Name
GSK Investigational Site
City
Benoni
ZIP/Postal Code
1501
Country
South Africa
Facility Name
GSK Investigational Site
City
Bloemfontein
ZIP/Postal Code
9301
Country
South Africa
Facility Name
GSK Investigational Site
City
Cape Town
ZIP/Postal Code
7441
Country
South Africa
Facility Name
GSK Investigational Site
City
Cape Town
ZIP/Postal Code
7500
Country
South Africa
Facility Name
GSK Investigational Site
City
Cape Town
ZIP/Postal Code
7572
Country
South Africa
Facility Name
GSK Investigational Site
City
Cape Town
ZIP/Postal Code
7700
Country
South Africa
Facility Name
GSK Investigational Site
City
Cape Town
ZIP/Postal Code
8001
Country
South Africa
Facility Name
GSK Investigational Site
City
CapeTown
ZIP/Postal Code
7764
Country
South Africa
Facility Name
GSK Investigational Site
City
Durban
ZIP/Postal Code
4001
Country
South Africa
Facility Name
GSK Investigational Site
City
Durban
ZIP/Postal Code
4071
Country
South Africa
Facility Name
GSK Investigational Site
City
Gatesville
ZIP/Postal Code
7764
Country
South Africa
Facility Name
GSK Investigational Site
City
Johannesburg
ZIP/Postal Code
1686
Country
South Africa
Facility Name
GSK Investigational Site
City
Korsten
ZIP/Postal Code
6014
Country
South Africa
Facility Name
GSK Investigational Site
City
Lynnwood Ridge
ZIP/Postal Code
0014
Country
South Africa
Facility Name
GSK Investigational Site
City
Mowbray
ZIP/Postal Code
7700
Country
South Africa
Facility Name
GSK Investigational Site
City
Paarl
ZIP/Postal Code
7646
Country
South Africa
Facility Name
GSK Investigational Site
City
Panorama
ZIP/Postal Code
7500
Country
South Africa
Facility Name
GSK Investigational Site
City
Potchefstroom
ZIP/Postal Code
2531
Country
South Africa
Facility Name
GSK Investigational Site
City
Pretoria
ZIP/Postal Code
0002
Country
South Africa
Facility Name
GSK Investigational Site
City
Pretoria
ZIP/Postal Code
0022
Country
South Africa
Facility Name
GSK Investigational Site
City
Roodepoort
ZIP/Postal Code
1724
Country
South Africa
Facility Name
GSK Investigational Site
City
Rooihuiskraal
ZIP/Postal Code
158
Country
South Africa
Facility Name
GSK Investigational Site
City
Somerset West
ZIP/Postal Code
7130
Country
South Africa
Facility Name
GSK Investigational Site
City
Thabazimbi
ZIP/Postal Code
0380
Country
South Africa
Facility Name
GSK Investigational Site
City
Tygerberg
ZIP/Postal Code
7505
Country
South Africa
Facility Name
GSK Investigational Site
City
Voorspoed
ZIP/Postal Code
9459
Country
South Africa
Facility Name
GSK Investigational Site
City
Badalona
ZIP/Postal Code
08916
Country
Spain
Facility Name
GSK Investigational Site
City
Barcelona
ZIP/Postal Code
08022
Country
Spain
Facility Name
GSK Investigational Site
City
Barcelona
ZIP/Postal Code
08025
Country
Spain
Facility Name
GSK Investigational Site
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
Facility Name
GSK Investigational Site
City
Barcelona
ZIP/Postal Code
08041
Country
Spain
Facility Name
GSK Investigational Site
City
Benidorm
ZIP/Postal Code
03501
Country
Spain
Facility Name
GSK Investigational Site
City
Canet De Mar - Barcelona
ZIP/Postal Code
08360
Country
Spain
Facility Name
GSK Investigational Site
City
Galdakano
ZIP/Postal Code
48960
Country
Spain
Facility Name
GSK Investigational Site
City
Illescas-Toledo
ZIP/Postal Code
45200
Country
Spain
Facility Name
GSK Investigational Site
City
Jerez de la Frontera
ZIP/Postal Code
11407
Country
Spain
Facility Name
GSK Investigational Site
City
L'Hospitalet de Llobregat
ZIP/Postal Code
08907
Country
Spain
Facility Name
GSK Investigational Site
City
Madrid
ZIP/Postal Code
28040
Country
Spain
Facility Name
GSK Investigational Site
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Facility Name
GSK Investigational Site
City
Mataró
ZIP/Postal Code
08303
Country
Spain
Facility Name
GSK Investigational Site
City
Oviedo
ZIP/Postal Code
33006
Country
Spain
Facility Name
GSK Investigational Site
City
Palma de Mallorca
ZIP/Postal Code
07010
Country
Spain
Facility Name
GSK Investigational Site
City
Pamplona
ZIP/Postal Code
31008
Country
Spain
Facility Name
GSK Investigational Site
City
Pozuelo De Alarcón/Madrid
ZIP/Postal Code
28223
Country
Spain
Facility Name
GSK Investigational Site
City
Sabadell (Barcelona)
ZIP/Postal Code
08208
Country
Spain
Facility Name
GSK Investigational Site
City
Sagunto/Valencia
ZIP/Postal Code
46520
Country
Spain
Facility Name
GSK Investigational Site
City
Sant Boi de Llobregat
ZIP/Postal Code
08830
Country
Spain
Facility Name
GSK Investigational Site
City
Santa Coloma de Gramenet
ZIP/Postal Code
08921
Country
Spain
Facility Name
GSK Investigational Site
City
Santiago de Compostela
ZIP/Postal Code
15706
Country
Spain
Facility Name
GSK Investigational Site
City
Torrelavega
ZIP/Postal Code
39300
Country
Spain
Facility Name
GSK Investigational Site
City
Valencia
ZIP/Postal Code
46017
Country
Spain
Facility Name
GSK Investigational Site
City
Vic (Barcelona)
ZIP/Postal Code
08500
Country
Spain
Facility Name
GSK Investigational Site
City
Changhua
ZIP/Postal Code
500
Country
Taiwan
Facility Name
GSK Investigational Site
City
Chia-Yi
ZIP/Postal Code
613
Country
Taiwan
Facility Name
GSK Investigational Site
City
Kaohsiung Hsien
ZIP/Postal Code
833
Country
Taiwan
Facility Name
GSK Investigational Site
City
Kaohsiung
ZIP/Postal Code
807
Country
Taiwan
Facility Name
GSK Investigational Site
City
Keelung
ZIP/Postal Code
20401
Country
Taiwan
Facility Name
GSK Investigational Site
City
LinKou
ZIP/Postal Code
333
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taichung
ZIP/Postal Code
40201
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taichung
ZIP/Postal Code
404
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taichung
ZIP/Postal Code
40705
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taichung
ZIP/Postal Code
433
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taichung
ZIP/Postal Code
437
Country
Taiwan
Facility Name
GSK Investigational Site
City
Tainan
ZIP/Postal Code
704
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taipei
ZIP/Postal Code
106
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taipei
ZIP/Postal Code
115
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taipei
ZIP/Postal Code
220
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taipei
ZIP/Postal Code
235
Country
Taiwan
Facility Name
GSK Investigational Site
City
Taipei
Country
Taiwan
Facility Name
GSK Investigational Site
City
Yung Kang City
ZIP/Postal Code
71044
Country
Taiwan
Facility Name
GSK Investigational Site
City
Bangkok
ZIP/Postal Code
10220
Country
Thailand
Facility Name
GSK Investigational Site
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Facility Name
GSK Investigational Site
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Facility Name
GSK Investigational Site
City
Bangkok
ZIP/Postal Code
10600
Country
Thailand
Facility Name
GSK Investigational Site
City
Bangkok
ZIP/Postal Code
10700
Country
Thailand
Facility Name
GSK Investigational Site
City
Chiangmai
ZIP/Postal Code
50200
Country
Thailand
Facility Name
GSK Investigational Site
City
Chiangrai
ZIP/Postal Code
57000
Country
Thailand
Facility Name
GSK Investigational Site
City
Khon Kaen
ZIP/Postal Code
40002
Country
Thailand
Facility Name
GSK Investigational Site
City
Mae Rim, Chiang Mai
ZIP/Postal Code
50180
Country
Thailand
Facility Name
GSK Investigational Site
City
Muang Phitsanulok
ZIP/Postal Code
53000
Country
Thailand
Facility Name
GSK Investigational Site
City
Muang
ZIP/Postal Code
11000
Country
Thailand
Facility Name
GSK Investigational Site
City
Nakhon Ratchasima
ZIP/Postal Code
30000
Country
Thailand
Facility Name
GSK Investigational Site
City
Phitsanulok
ZIP/Postal Code
65000
Country
Thailand
Facility Name
GSK Investigational Site
City
Songkla
ZIP/Postal Code
90110
Country
Thailand
Facility Name
GSK Investigational Site
City
Ankara
ZIP/Postal Code
06280
Country
Turkey
Facility Name
GSK Investigational Site
City
Ankara
ZIP/Postal Code
06500
Country
Turkey
Facility Name
GSK Investigational Site
City
Ankara
ZIP/Postal Code
06510
Country
Turkey
Facility Name
GSK Investigational Site
City
Ankara
ZIP/Postal Code
06590
Country
Turkey
Facility Name
GSK Investigational Site
City
Ankara
ZIP/Postal Code
6030
Country
Turkey
Facility Name
GSK Investigational Site
City
Bursa
ZIP/Postal Code
16059
Country
Turkey
Facility Name
GSK Investigational Site
City
Istanbul
ZIP/Postal Code
34020
Country
Turkey
Facility Name
GSK Investigational Site
City
İstanbul
ZIP/Postal Code
34098
Country
Turkey
Facility Name
GSK Investigational Site
City
Istanbul
ZIP/Postal Code
34844
Country
Turkey
Facility Name
GSK Investigational Site
City
Istanbul
ZIP/Postal Code
34899
Country
Turkey
Facility Name
GSK Investigational Site
City
Istanbul
ZIP/Postal Code
61080
Country
Turkey
Facility Name
GSK Investigational Site
City
Kocaeli
ZIP/Postal Code
41380
Country
Turkey
Facility Name
GSK Investigational Site
City
Konya
ZIP/Postal Code
42080
Country
Turkey
Facility Name
GSK Investigational Site
City
Samsun
ZIP/Postal Code
55139
Country
Turkey
Facility Name
GSK Investigational Site
City
Alupka
ZIP/Postal Code
98676
Country
Ukraine
Facility Name
GSK Investigational Site
City
Cherkassy
ZIP/Postal Code
18009
Country
Ukraine
Facility Name
GSK Investigational Site
City
Chernihiv
ZIP/Postal Code
14034
Country
Ukraine
Facility Name
GSK Investigational Site
City
Chernivtsi
ZIP/Postal Code
58022
Country
Ukraine
Facility Name
GSK Investigational Site
City
Dnipropetrovsk
ZIP/Postal Code
49005
Country
Ukraine
Facility Name
GSK Investigational Site
City
Dnipropetrovsk
ZIP/Postal Code
49027
Country
Ukraine
Facility Name
GSK Investigational Site
City
Dnipropetrovsk
ZIP/Postal Code
49064
Country
Ukraine
Facility Name
GSK Investigational Site
City
Dnipropetrovsk
ZIP/Postal Code
49074
Country
Ukraine
Facility Name
GSK Investigational Site
City
Dnipropetrovsk
ZIP/Postal Code
49102
Country
Ukraine
Facility Name
GSK Investigational Site
City
Donetsk
ZIP/Postal Code
83003
Country
Ukraine
Facility Name
GSK Investigational Site
City
Donetsk
ZIP/Postal Code
83045
Country
Ukraine
Facility Name
GSK Investigational Site
City
Donetsk
ZIP/Postal Code
83059
Country
Ukraine
Facility Name
GSK Investigational Site
City
Donetsk
ZIP/Postal Code
83114
Country
Ukraine
Facility Name
GSK Investigational Site
City
Ivano-Frankivsk
ZIP/Postal Code
76005
Country
Ukraine
Facility Name
GSK Investigational Site
City
Ivano-Frankivsk
ZIP/Postal Code
76008
Country
Ukraine
Facility Name
GSK Investigational Site
City
Ivano-Frankivsk
ZIP/Postal Code
76018
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61001
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61002
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61018
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61022
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61039
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61046
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61103
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61124
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kharkiv
ZIP/Postal Code
61157
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kherson
ZIP/Postal Code
73000
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kiev
ZIP/Postal Code
02660
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kiev
ZIP/Postal Code
03680
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kryvyi Rig
ZIP/Postal Code
50096
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
03038
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
03049
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
03179
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
03680
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
04114
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
04201
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
1680
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
4050
Country
Ukraine
Facility Name
GSK Investigational Site
City
Kyiv
ZIP/Postal Code
4107
Country
Ukraine
Facility Name
GSK Investigational Site
City
Lutsk
ZIP/Postal Code
43024
Country
Ukraine
Facility Name
GSK Investigational Site
City
Lviv
ZIP/Postal Code
79010
Country
Ukraine
Facility Name
GSK Investigational Site
City
Lviv
ZIP/Postal Code
79015
Country
Ukraine
Facility Name
GSK Investigational Site
City
Mykolaiv
ZIP/Postal Code
54003
Country
Ukraine
Facility Name
GSK Investigational Site
City
Odesa
ZIP/Postal Code
65010
Country
Ukraine
Facility Name
GSK Investigational Site
City
Odesa
ZIP/Postal Code
65114
Country
Ukraine
Facility Name
GSK Investigational Site
City
Odessa
ZIP/Postal Code
65009
Country
Ukraine
Facility Name
GSK Investigational Site
City
Odessa
ZIP/Postal Code
65025
Country
Ukraine
Facility Name
GSK Investigational Site
City
Poltava
ZIP/Postal Code
36024
Country
Ukraine
Facility Name
GSK Investigational Site
City
Poltava
ZIP/Postal Code
36028
Country
Ukraine
Facility Name
GSK Investigational Site
City
Poltava
ZIP/Postal Code
36038
Country
Ukraine
Facility Name
GSK Investigational Site
City
Simferopol
ZIP/Postal Code
95043
Country
Ukraine
Facility Name
GSK Investigational Site
City
Sumy
ZIP/Postal Code
40022
Country
Ukraine
Facility Name
GSK Investigational Site
City
Sumy
ZIP/Postal Code
40030
Country
Ukraine
Facility Name
GSK Investigational Site
City
Sympheropol
ZIP/Postal Code
95017
Country
Ukraine
Facility Name
GSK Investigational Site
City
Ternopil
ZIP/Postal Code
46002
Country
Ukraine
Facility Name
GSK Investigational Site
City
Uzhhorod
ZIP/Postal Code
88000
Country
Ukraine
Facility Name
GSK Investigational Site
City
Uzhhorod
ZIP/Postal Code
88009
Country
Ukraine
Facility Name
GSK Investigational Site
City
Uzhhorod
ZIP/Postal Code
88017
Country
Ukraine
Facility Name
GSK Investigational Site
City
Vinnytsia
ZIP/Postal Code
21018
Country
Ukraine
Facility Name
GSK Investigational Site
City
Vinnytsia
ZIP/Postal Code
21029
Country
Ukraine
Facility Name
GSK Investigational Site
City
Vinnytsya
ZIP/Postal Code
21001
Country
Ukraine
Facility Name
GSK Investigational Site
City
Yalta
ZIP/Postal Code
98603
Country
Ukraine
Facility Name
GSK Investigational Site
City
Zaporizhia
ZIP/Postal Code
69035
Country
Ukraine
Facility Name
GSK Investigational Site
City
Zaporizhzhia
ZIP/Postal Code
69106
Country
Ukraine
Facility Name
GSK Investigational Site
City
Zaporizhzhia
ZIP/Postal Code
69118
Country
Ukraine
Facility Name
GSK Investigational Site
City
Zaporizhzhia
ZIP/Postal Code
69600
Country
Ukraine
Facility Name
GSK Investigational Site
City
Zaporizhzhya
ZIP/Postal Code
69001
Country
Ukraine
Facility Name
GSK Investigational Site
City
Zhytomyr
ZIP/Postal Code
10002
Country
Ukraine
Facility Name
GSK Investigational Site
City
Bedford
State/Province
Bedfordshire
ZIP/Postal Code
MK404AW
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Bedford
State/Province
Bedfordshire
ZIP/Postal Code
MK42 9DJ
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Peterborough
State/Province
Cambridgeshire
ZIP/Postal Code
PE8 6PL
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Soham
State/Province
Cambridgeshire
ZIP/Postal Code
CB7 5JD
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Chesterfield
State/Province
Derbyshire
ZIP/Postal Code
S40 4AA
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Buckshaw Village, Chorley
State/Province
Lancashire
ZIP/Postal Code
PR7 7NA
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Liverpool
State/Province
Merseyside
ZIP/Postal Code
L9 7AL
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Waterloo, Liverpool
State/Province
Merseyside
ZIP/Postal Code
L22 0LG
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Northwood
State/Province
Middlesex
ZIP/Postal Code
HA6 2RN
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Bury St Edmunds
State/Province
Suffolk
ZIP/Postal Code
IP30 9QU
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Bexhill-on-Sea
ZIP/Postal Code
TN40 1JJ
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Birmingham
ZIP/Postal Code
B9 5SS
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Brighton
ZIP/Postal Code
BN2 5BE
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Cardiff
ZIP/Postal Code
CF14 5GJ
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Chelmsford
ZIP/Postal Code
CM1 7ET
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Derby
ZIP/Postal Code
DE22 3NE
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Edgbaston, Birmingham
ZIP/Postal Code
B15 2SQ
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Edinburgh
ZIP/Postal Code
EH16 4SA
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Glasgow
ZIP/Postal Code
G20 0SP
Country
United Kingdom
Facility Name
GSK Investigational Site
City
London
ZIP/Postal Code
EC1M 6BQ
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Manchester
ZIP/Postal Code
M15 6SX
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Milton Keynes
ZIP/Postal Code
MK6 5LD
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Reading
ZIP/Postal Code
RG2 0TG
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Sidcup, Kent
ZIP/Postal Code
DA14 6LT
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Tyne And Wear
ZIP/Postal Code
NE29 8NH
Country
United Kingdom
Facility Name
GSK Investigational Site
City
Can Tho
ZIP/Postal Code
90000
Country
Vietnam
Facility Name
GSK Investigational Site
City
Ha Noi
ZIP/Postal Code
10000
Country
Vietnam
Facility Name
GSK Investigational Site
City
Ho Chi Minh
ZIP/Postal Code
70000
Country
Vietnam
Facility Name
GSK Investigational Site
City
Hue
ZIP/Postal Code
53000
Country
Vietnam

12. IPD Sharing Statement

Citations:
PubMed Identifier
32764918
Citation
Horne BD, Hegewald MJ, Crim C, Rea S, Bair TL, Blagev DP. The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020 Jul 20;15:1741-1750. doi: 10.2147/COPD.S254437. eCollection 2020.
Results Reference
derived
PubMed Identifier
32441114
Citation
Wise RA, Anderson JA, Amarenco P, Cowans NJ, Crim C, Denvir MA, Gomez CR, Jones MP, Morris A, Niewoehner D, Yates JC. Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial. Clin Trials. 2020 Aug;17(4):430-436. doi: 10.1177/1740774520920897. Epub 2020 May 22.
Results Reference
derived
PubMed Identifier
31258919
Citation
Celli BR, Anderson JA, Brook R, Calverley P, Cowans NJ, Crim C, Dixon I, Kim V, Martinez FJ, Morris A, Newby DE, Yates J, Vestbo J. Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial. BMJ Open Respir Res. 2019 May 4;6(1):e000431. doi: 10.1136/bmjresp-2019-000431. eCollection 2019.
Results Reference
derived
PubMed Identifier
31068182
Citation
Fawzy A, Anderson JA, Cowans NJ, Crim C, Wise R, Yates JC, Hansel NN. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD. Respir Res. 2019 May 8;20(1):86. doi: 10.1186/s12931-019-1059-1.
Results Reference
derived
PubMed Identifier
30815468
Citation
Vestbo J, Dransfield M, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez F, Newby DE, Yates J, Lange P. Impact of pre-enrolment medication use on clinical outcomes in SUMMIT. ERJ Open Res. 2019 Feb 25;5(1):00203-2018. doi: 10.1183/23120541.00203-2018. eCollection 2019 Feb.
Results Reference
derived
PubMed Identifier
30165984
Citation
Adamson PD, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Mills NL. Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease. J Am Coll Cardiol. 2018 Sep 4;72(10):1126-1137. doi: 10.1016/j.jacc.2018.06.051. Erratum In: J Am Coll Cardiol. 2018 Oct 30;72(18):2282.
Results Reference
derived
PubMed Identifier
29442524
Citation
Kunisaki KM, Dransfield MT, Anderson JA, Brook RD, Calverley PMA, Celli BR, Crim C, Hartley BF, Martinez FJ, Newby DE, Pragman AA, Vestbo J, Yates JC, Niewoehner DE; SUMMIT Investigators. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57. doi: 10.1164/rccm.201711-2239OC.
Results Reference
derived
PubMed Identifier
29412688
Citation
Celli B, Anderson JA, Brook R, Calverley P, Crim C, Holmes AP, Martinez FJ, Newby DE, Yates J, Vestbo J; SUMMIT Investigators. Long-Acting beta-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial. Am J Respir Crit Care Med. 2018 Jun 15;197(12):1641-1644. doi: 10.1164/rccm.201710-2052LE. No abstract available.
Results Reference
derived
PubMed Identifier
29406772
Citation
Dransfield MT, McAllister DA, Anderson JA, Brook RD, Calverley PMA, Celli BR, Crim C, Gallot N, Martinez FJ, Scanlon PD, Yates J, Vestbo J, Newby DE; SUMMIT Investigators. beta-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT. Ann Am Thorac Soc. 2018 May;15(5):608-614. doi: 10.1513/AnnalsATS.201708-626OC.
Results Reference
derived
PubMed Identifier
29348179
Citation
Bhatt SP, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Newby DE, Vestbo J, Yates JC, Dransfield MT. Cigarette smoking and response to inhaled corticosteroids in COPD. Eur Respir J. 2018 Jan 18;51(1):1701393. doi: 10.1183/13993003.01393-2017. Print 2018 Jan. No abstract available.
Results Reference
derived
PubMed Identifier
28947039
Citation
Crim C, Calverley PMA, Anderson JA, Holmes AP, Kilbride S, Martinez FJ, Brook RD, Newby DE, Yates JC, Celli BR, Vestbo J; SUMMIT investigators. Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial. Respir Med. 2017 Oct;131:27-34. doi: 10.1016/j.rmed.2017.07.060. Epub 2017 Aug 1.
Results Reference
derived
PubMed Identifier
28737971
Citation
Calverley PMA, Anderson JA, Brook RD, Crim C, Gallot N, Kilbride S, Martinez FJ, Yates J, Newby DE, Vestbo J, Wise R, Celli BR; SUMMIT (Study to Understand Mortality and Morbidity) Investigators. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. Am J Respir Crit Care Med. 2018 Jan 1;197(1):47-55. doi: 10.1164/rccm.201610-2086OC.
Results Reference
derived
PubMed Identifier
28416587
Citation
Brook RD, Anderson JA, Calverley PM, Celli BR, Crim C, Denvir MA, Magder S, Martinez FJ, Rajagopalan S, Vestbo J, Yates J, Newby DE; SUMMIT Investigators. Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk. Heart. 2017 Oct;103(19):1536-1542. doi: 10.1136/heartjnl-2016-310897. Epub 2017 Apr 17.
Results Reference
derived
PubMed Identifier
27767328
Citation
Martinez FJ, Vestbo J, Anderson JA, Brook RD, Celli BR, Cowans NJ, Crim C, Dransfield M, Kilbride S, Yates J, Newby DE, Niewoehner D, Calverley PM; SUMMIT Investigators. Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction. Am J Respir Crit Care Med. 2017 Apr 1;195(7):881-888. doi: 10.1164/rccm.201607-1421OC.
Results Reference
derived
PubMed Identifier
27203508
Citation
Vestbo J, Anderson JA, Brook RD, Calverley PM, Celli BR, Crim C, Martinez F, Yates J, Newby DE; SUMMIT Investigators. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet. 2016 Apr 30;387(10030):1817-26. doi: 10.1016/S0140-6736(16)30069-1. Epub 2016 Apr 28.
Results Reference
derived
PubMed Identifier
23018908
Citation
Vestbo J, Anderson J, Brook RD, Calverley PM, Celli BR, Crim C, Haumann B, Martinez FJ, Yates J, Newby DE. The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol. Eur Respir J. 2013 May;41(5):1017-22. doi: 10.1183/09031936.00087312. Epub 2012 Sep 27.
Results Reference
derived
Links:
URL
https://www.clinicalstudydatarequest.com
Description
Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
Available IPD and Supporting Information:
Available IPD/Information Type
Statistical Analysis Plan
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register
Available IPD/Information Type
Clinical Study Report
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register
Available IPD/Information Type
Individual Participant Data Set
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register
Available IPD/Information Type
Annotated Case Report Form
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register
Available IPD/Information Type
Informed Consent Form
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register
Available IPD/Information Type
Dataset Specification
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register
Available IPD/Information Type
Study Protocol
Available IPD/Information URL
https://www.clinicalstudydatarequest.com
Available IPD/Information Identifier
113782
Available IPD/Information Comments
For additional information about this study please refer to the GSK Clinical Study Register

Learn more about this trial

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

We'll reach out to this number within 24 hrs